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Rac small GTP-binding protein involved in regulating actin c�toskeleton
RGS regulator of G-protein signaling
Rho small GTPase, which controls a wide variet� of signal transduction   
                               pathwa�s
SDS sodiumdodec�lsulfate
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1	 Introduction
 Almost all internal and external responses of the organism are mediated b� the re-
ceptor activit�. Receptors are necessar� for detection and transduction of signals not onl�         
inside the organism, but also for communication between living beings. It is rather eas� to 
sustain these functions in single cell organisms or in simple Metazoa, but it is extremel� dif-
ficult task to maintain all these signal flows in multicellular organisms such as mammals, be-
cause all cells and the organs itself should act as a well conducted orchestra. To support such     
a sophisticated task, nature has created a wide variet� of the receptors, which generall� can 
be classified in five distinct classes  (Bockaert and Pin 1999). The first class combines recep-
tors which are responsible for the communication between cells. C�tokine receptors are t�p-
ical members of this group. The second class controls interactions between the cells and the 
extracellular matrix (e.g. integrine receptors). T�rosine kinase receptor used as receptors for     
growth factors are collected in the third class. Ligand-gated ion channels, which are in the        
class four, are used for transmitting the ions across the plasma membrane. The� rela� dif-  
ferent signals b� changing the permeabilit� of the membrane. However, the most common         
class of the receptors is G-protein coupled receptors (GPCRs). This group mediates a wide 
variet� of signals via interaction of the receptor and guanine nucleotide-binding regulator� 
proteins termed G-proteins. The G-proteins in turn activate diverse second messengers. 
1.1 G-protein coupled receptors
 G-protein coupled receptors represent a superfamil� of receptors with hundreds of        
affiliates (Bockaert and Pin 1999).  GPCRs are perfectly designed for recognition of many 
internal messenger molecules (such as hormones, neurotransmitters, growth factors and 
man� others), and a number of external signals such as light, odors and gustative molecules 
b� regulating the activit� of the G-proteins. All members of the GPCR famil� have a com-              
mon feature; the� consist of seven transmembrane domains, 3 extracellular and 3 intracellu-
lar loops, N- and C-ends (Figure 1.1). In invertebrates, more than 1 percent of the genome is 
responsible for coding of the GPCRs. This comprises 2000 receptors, including more than a 
thousand receptors for odorants and pheromone receptors. For example Caenorhabditis ele-
gance, its genome encodes roughl� one thousand and hundred receptors (5% of the genome) 
(Bargmann 1998). GPCRs represent the oldest tools regulating signal transduction in plants 
(Plakidou-D�mock et al. 1998), �easts (Dohlman et al. 1991) and mold Dictyostelium dis-
coideum (Devreotes 1994). In vertebrates, GPCRs pla�s also a ver� important role in organ-
ism functioning, beside this GPCRs serve as pharmacological targets to treat some patho-
ph�siological conditions (Angers et al. 2001, Bockaert and Pin 1999, McCudden et al. 2005, 
Thompson et al. 2005, Vassilatis et al. 2003). Based on differences in sequence, GPCRs are 
divided into four distinct sub-classes: A, B, C and F/S (Horn et al. 1998). The diversit� and 
versatilit� of the GPCRs are illustrated in the Figure 1.2. 
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Figure 1.1 The GPCRs are the largest protein famil� known. Which members are involved in all t�pes 
of stimulus response pathwa�s, from intercellular communication to ph�siological senses. The diversit� 
of functions is matched b� the wide range of ligands recognized b� GPCRs, from photons (rhodopsin) and 
small molecules (in the case of the histamine receptors) to proteins (for example, chemokine receptors).                          
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Family A (rhodopsin like receptors) represents the largest GPCRs famil�. 
Nevertheless, it can be subdivided into three subfamilies: 1, 2 and 3 b� sequence anal�sis 
and t�pe of stimulus. Group 1 contains receptors for small ligands like catecholamines or 
light. In case of catecholamines, ligand binding occurs in a space formed b� TMD III and 
TMD VI. Rhodopsin, which is target of photons, is covalentl� linked in this space and its 
conformational changes activate the G-protein. Receptors that belong to the group 2 are usu-
all� activated b� small peptides, which interact with N-terminal and exctracellular loops 
(glucagon and secretin receptors) (Bockaert and Pin 1999). Group three is characterized b� 
a huge exctracellular domain, which is responsible for binding of gl�coprotein hormones 
(receptors for TSH and FSH) (Bockaert and Pin 1999). All receptors from famil� A possess 
some common features; all of them have highl� conserved ke� residues involved in the for-
mation of a disulfide bridge, which connects the second (e
2
) and third (e
3
) extracellular loop. 
In addition, most of the members have a palmito�lated c�steine in the C-terminal domain 
causing the formation of a putative fourth intracellular loop (Figure 1.2) (Gether 2000). 
 Family B contains receptors, which are activated b� large proteins such as parath�-
roid hormone, pituitar� aden�late c�clase-activating pol�peptide (PACAP) and secretin. 
The relativel� large (100 amino acids) N-terminal domain also pla�s a role in ligand binding 
similar to the receptors from Famil� A. It also contains several c�steine residues, which ma� 
form a network of disulfide bridges (Figure 1.2) (Gether 2000).
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Figure 1.2 GPCR superfamil� can be devided into 3 main subfamilies (corresponding ligands are shown 
below of the receptor,        – characteristic amino acids are shown with the single-letter code,     – palmi�lation, 
       – ligand binding area ). Famil� A contains most of the receptors, including receptors for odorants, small 
ligands, such as serotonin, catecholamines, opiates and gl�coproteins hormones. Receptors from the Famil� B 
are activated b� a large proteins, such as parath�roid hormone, calcitonin etc. Members of the Famil� C inter-
act with glutamate, GABA and are also responsible for taste and pheromones recognition. 
D
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 Family C receptors include the metabotropic glutamate, GABA
B
, calcium receptors, 
taste and pheromone receptors. The ligand-binding site of these receptors is located within 
the large extracellular N domain (Figure 1.2) (Gether 2000). 
A growing number of researchers reports that the GPCRs can act not onl� as mono-
mers, but also as functional oligomers (Fotiadis et al. 2006, Herrick-Davis et al. 2004, 
Nakata et al. 2005). Interestingl�, the presence of agonist has been shown to stabilize the di-
mers of several receptors including β2-adrenergic receptor (Hebert et al. 1996) and chemo-
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Pi
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Effectors
Figure 1.3 G-protein c�cle. Activation of the G-protein leads to the exchange of GDP to GTP on alpha sub-
unit, which leads to dissociation of the α subunit from the βγ complex. Each part can trigger their own targets. 
RGS protein can regulate process of GDP/GTP exchange, and b� this affect G-protein related signaling.
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kine receptor CCR2b (Rodriguez-Frade et al. 1999). This suggests that oligomerisation ma� 
pla� a role either directl� in the receptor activation or in subsequent receptor agonist-depen-
dent internalisation and desensitization. Homooligomers and heterooligomers ma� have a 
different pharmacological properties and altered internalisation kinetics (Han�aloglu et al. 
2002). 
 The impact of GPCRs on a pathological state of the organism has been well docu-
mented. GPCRs are involved in a wide range of disorders such as allergies, depression, 
cancer, obesit�, pain, diabetes and man� others (Lundstrom 2005, Tang and Insel 2005, 
Thompson et al. 2005). Around 75% of all drugs on the market targets GPCRs  and the 
number is growing every year, giving a billions dollars of profit to pharmaceutical compa-
nies (Lundstrom 2005). 
1.2	 G-protein	mediated	signaling
Heterotrimeric G-proteins act as intracellular partners of GPCRs. The G-proteins con-
sist of 3 subunits: α, β and γ (Gilman 1987). The activation c�cle of G-proteins involve re-
current GTP association with the alpha subunit, h�drol�sis of GTP to GDP and P
i
, followed 
b� dissociation of GDP. Binding of GTP is associated with dissociation of the αβγ complex 
into α and βγ subcomplexes and triggering of the appropriate effectors. The c�cle is regulat-
ed b� regulators of G-protein signaling or RGS proteins (Siederovski al., 1996), which bind 
to the Gα subunit and enhance GTP h�drol�sis (Tesmer et al. 1997). Moreover, RGS pro-
teins are recognized not onl� as ke� regulator of the signaling but also as scaffolds that coor-
dinate parts of GPCR signaling (Figure 1.3).
 The molecular weight of Gα subunits varies from 39 to 45 kDa. It possesses N-termi-
nal modifications including covalently attached fatty acids myristate (14-carbon fatty acid) 
and/or palmitate (16-carbon fatt� acid). All Gα subunits excluding the Gα
t
 or transducin 
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contain palmitate reversibly attached to a cysteine on the N-terminus. Fatty acid modifica-
tions are crucial for the Gα subunit membrane localization (Peitzsch and McLaughlin 1993, 
Wedeetgaertner al., 1995). Based on their distinct features α subunits are divided into four 
subfamilies: Gα
S
, Gα
i
, Gα
q
 and Gα
12/13
 (McCudden et al. 2005). 
Gα
S
-proteins. The first identified downstream molecule, which is affected by 
G-proteins, was adenylate cyclases (AC). It was discovered by Sutherland in late fifties 
(Sutherland and Rall 1958). Twent� �ears later, the connection between the G-pro­teins and 
the AC was made b� Ross and Gilman who isolated the Gα
s
 protein and demonstarted that 
Gα
s
 can activate AC (­Ross and Gilman 1977). Gαolf-protein,­which­is­a­shorter­(80­amino­
acids)­version­of­GαS,­also­positively­linked­to­adenylyl­cyclases,­is­found­in­the­olfactory­
system,­where­it­serves­an­imperative­task­of­olfactory­signal­transduction­(Liu­et­al.­2001).­
Gαi-proteins were identified by Smith and Limbrid (Smith and Limbird 1982). In 
contrast­to­GαS­activation­of­Gαi subunits therefore leads subsequent decrease of cAMP lev-
els via the inhibition of AC (Albert et al. 1996, Barnes and Sharp 1999, Emerit et al. 1990, 
Varrault et al. 1992). 
Gαq-proteins interact with phospholipase C (PLC) isoforms (Blank et al. 1991). 
PLCs hydrolyze the phosphoester bond of the plasma membrane lipid phosphatidylinositol 
4,5-bisphosphate, generating the ubiquitous second messengers inositol 1,4,5-trisphosphate 
(Ins(1,4,5)P3) and diacylglycerol (DAG).
Gα12/13 proteins activate small GTPases and are important for regulation of the cyto-
skeleton, cell junctions, and other processes related to cell shape movements (Collins et al. 
1996, Voyno-Yasenetskaya et al. 1996, Wadsworth et al. 1997).
Up to now more than 5 different β and 12 γ subunits have been identified (Hur and 
Kim 2002, McCudden et al. 2005, Nurnberg et al. 1995). Gβ/γ subunits have a bigger vari-
et� than Gα, ensuing a bigger number of potential combinations of Gβ/γ dimers. All γ sub-
units are post-translationale modified by prenylation of the C-terminus (Wedegaertner et al. 
1995).  This modification of Gγ subunit works as a membrane anchor attached to the cell 
membrane. In early studies it has been suggested that Gβ/γ dimers­serve­as­adaptors­to­pro-
mote coupling of G-protein heterotrimers to GPCRs, plus act as Gα inhibitors. Now it is 
widely­accepted­that­Gβ/γ dimers play an important role not only as adaptors but also by 
direct ctivation of diffirent effectors. The first proved partner for Gβ/γ­dimer­was­G-pro-
tein regulated inward rectifier K+ channels (GIRK) (Logothetis et al. 1987). Since than, 
many­new­discoveries­were­made,­it­is­known­that­Gβγ dimers can regulate Ca2+­channels,­
PLCβ, p38 mitogen activated protein kinases (MAPKs), MAPK scaffold proteins, or may 
participate in membrane attachment of Rho and Rac. Recently it was shown that adenyl-
ate cyclases can be regulated not only by Gα, but also by Gβγ heterodimer (Akgozuchi et 
al. 2002, Coso et al. 1996, Faure et al. 1994, Harhammer et al. 1996, Sunahara and Taussig 
2002, Yamaet al. 1997). 
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1.3 Regulation of GPCR activity
1.3.1	 β-arrestin	mediated	desensitization	as	the	key	regulatory	
mechanism
The power and time of second messenger response are regulated b� the process 
named desensitization, and almost all GPCRs undergo this process (Figure 1.4) (Claing and 
Laporte 2005). Desensitization starts with phosphorylation of specific serine or threonine 
residues b� GPCR kinases (GRKs). These phosphor�lation sites are located in the intracel-
lular domains of the receptor preferentiall� in the receptor carbox�l terminus (Bunemann 
and Hose� 1999). According to the paradigm, established mainl� in the β2-adrenergic recep-
tor s�stem, phosphor�lation on serine or threonine residues promotes β-arrestin binding to 
the receptor, which is recruited from the c�toplasm and serves as blocker for further receptor 
coupling to its G-protein (Claing and Laporte 2005). 
Four different arrestins have been described so far. Two of them are found in the vi-
sual s�stem. One is found exclusivel� in rods, the other one in the cones and both are in-
volved in desensitization of the rhodopsin receptor onl�. Other two arrestins can be found 
almost in all cells. The� are known as β-arrestin1 and β-arrestin2 and promote desensitiza-
tion of most receptors (Han et al. 2001, Lohse et al. 1990). In addition to the receptor desen-
sitization, β-arrestins also serve as adaptor proteins for receptor endocytosis and trafficking. 
After being desensitized, receptors ma� undergo internalization, and β-arrestin pla�s 
the ke� role in this process b� providing a link between the receptor and the endoc�tosis ma-
chiner�.  Arrestin recruits clathrin and AP-2 and controls the formation of the clathrin-coat-
ed pit. This complex recruits another protein, d�namin, which posses GTPase activit�. As a 
vesicle invaginates, d�namin forms a spiral around the neck of the vesicle. Once the spiral is 
in place, it extends lengthwise and constricts through GTP h�drol�sis. This lengthening and 
tightening of the coil around the vesicle neck causes it to break and results in formation of 
the endosomal vesicle. B� this, receptor can be either degraded or rec�cled (Figure 1.4). 
Noteworth�, β-arrestin proteins ma� act not onl� as adaptors during desensetiza-
tio/internalisation process, but also can transmit signals in a cell independentl� of classical 
GPCR related signaling pathwa�s. For example, it can recruit non-receptor t�rosine kinases 
of the Src famil� to regulate downstream cascades, such as MAPK pathwa�  (Claing and 
Laporte 2005, Lohse et al. 1990). 
1.4 Serotonin receptors
Serotonin or 5-h�drox�tr�ptamine (5-HT) is one of major neurotransmitters in verte-
brates. It was firstly described by Maurice Rapport and Irvine Page in 1948 as a substance in 
blood serum, responsible for contraction of  blood vessels (Rapport et al. 1948), later it has 
been shown that serotonin ma� act as neurotransmitter (Twarog 1953). 
In mammals, the function of 5-HT is mediated by specific receptors. With e�ception        
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Figure 1.4 GPCR desensitization and internalization via GRK phosphor�lation and β-arrestin 
recruitment. After receptor activation, GRK2 (        ) is recruited from the c�toplasm, and phosphor�-
lates serine/threonine residues on the C-terminus of the receptor. Phosphor�lated part of the receptor 
became accessible for the special adaptor protein – β-arrestin (           ), which binds to the phosphor-
�lated (      ) part of the receptor and makes receptor inaccessible for further G-protein related signal-
ing. This process is known as desensitization. After desensitization, clathrin (       ) binds to a specific 
clathrin binding motif of the ß-arrestin. Binding of clathrin to the receptor–β-arrestin complex starts 
a formation of clathrin-coated vesicle, which will be removed from the membrane with help of the 
d�namin (     ). Some other proteins are also involved in this process, such as AP-2 (         ) which is 
an adaptor protein. After being removed from the membrane, vesicle can go for the rapid rec�cling 
of the receptor or receptor undergoes degradation
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of the 5-HT3 receptor, which is a ligand gated ion channel (Kroeze et al. 2002), all other 
5-HT receptors belong to the GPCRs superfamil�. The six classes of serotonin receptors are     
further subdivided b� thirteen receptors t�pes, based on sequence and pharmacological simi-
larities. The serotonergic G-protein coupled receptors are t�pical members of the 1A famil�. 
Ligands that bind to 5-HT receptor interact with amino acids located  in the transmembrane 
helices. Until now, the structure of the 5-HT receptors has not been solved. (Kroeze et al. 
2002).
The­5-HT1A receptor is the best characterized 5-HT receptor. This receptor is cou-
pled­to­heterotrimeric­G-proteins­of­the­Gαi/o­family­(Figure 1.5) (Albert et al. 1996). 
Examination of G-protein specificity for the 5-HT1A receptor discovered a surprising com-
plexity. Elimination of Gαi1 abolishes receptor mediated inhibition of basal cAMP levels, 
whereas­removal­of­Gαi2­and­Gαi3 inhibits the 5-HT1A receptor action on Gαs-activated­ad-
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5-HT2C
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5-HT1F
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Figure 1.5 Serotonin ma� activate 7 distinct classes of serotonin receptors. 6 of them a are classical 7 
transmembrane domain G-protein coupled receptors, and 5-HT3 is a ligand-gated Na+/K+ channel. 5-HT1 
and 5-HT5 receptors inhibit s�ntehis�s of cAMP via activation of Gα
i
; 5-HT
4
, 5-HT7 and 5-HT6 stimulates 
production of cAMP via coupling to Gα
S
 protein. 5-HT2 regulates phospholipase C pathwa� via activation of 
Gα
q
. Recentl� it has been shown that 5-HT
4
 ma� also activate Gα
13
 and 5-HT7 ma� activate Gα
12
 proteins.
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enylate cyclase (AC) (Liu et al. 1999). In addition, stimulation of the 5-HT1A receptor leads 
to­a­Gαi-mediated activation of K+ current and inhibition of Ca2+ current. In CHO cells, the 
5-HT1A receptor also mediates Gβγ-mediated­stimulation­of­mitogen-activated­protein­ki-
nase Erk2 as well as activation of phospholipase C (Berg and Clarke 2001, Chen et al. 2002, 
Cowen et al. 1996, Mendez et al. 1999). Studies in Sf.9 insect cells also gave evidences for 
post-translational modifications of the 5-HT1A receptor (Butkerait et al. 1995, Papoucheva 
et al. 2004). Significant attention to this receptor is based on studies demonstrating a role for 
the 5-HT1A receptor in anxiety and depression disorders (Dawson et al. 2006, Delgado et al. 
2005, Fricker et al. 2005, Lanfumey and Hamon 2004).    
The 5-HT2 receptor famil� contains three subt�pes. These receptors are positivel� 
couple to Gα
q/11
 proteins and activate phospholipase C (Figure 1.5). The amino acid se-
quence is ver� similar among these receptors, but the� are structurall� distinct from other 
5-HT receptors (Barnes and Sharp 1999). The 5-HT2 receptor can be found in the forebrain, 
olfactor� nuclei, hippocampus, substantia nigra, and globus pallidus; outside the CNS in the 
lungs, and the spleen.  The� ma� regulate feeding and hormone secretion as well as locomo-
tion and temperature control (Barnes and Sharp 1999).
The 5-HT3 receptor is distinct from all other 5-HT receptors, because it’s the ligand 
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gated K+/Na+ ion channel. Until now onl� one gene encoding the 5-HT3 receptor was found 
in humans. The 5-HT3 receptor shows high level of identit� to the C�s-C�s loop ligand gat-
ed ion channel superfamil� (nicotinic, GABA
A
 and gl�cine receptors). It can be found in the 
dorsal vagal compound of the brainstem, hippocampus, am�gdala, and the cerebral cortex 
(Barnes and Sharp 1999). It ma� pla� an important role in some t�pes of pain responses, lo-
comotion and cognition (Koeze at al. 2002).
The 5-HT
4
 receptor famil� consist of the seven splice variants of the same gene, 
products of alternative splicing at the C-terminus. All of them are coupled to the Gα
S
 pro-
tein which activate AC (Figure 1.5) (Barnes and Sharp 1999). The 5-HT
4(b)
 receptor is also 
coupled to Gα
i/o
 protein, and 5-HT
4(a)
 receptor can activates Gα
13
 leading to activation of the 
RhoA small GTPase (Ponimaskin et al. 2002a). 5-HT
4
 receptors are localized in the basal 
ganglia, the hippocampus, the olfactor� tubercule and respirator� nucleus. The 5-HT
4
 recep-
tor pla�s a ver� important role in cognition and respirator� c�cle (Barnes and Sharp 1999, 
Manzke et al. 2003). It has been­shown­to­mediate­several­important­physiological­effects­
of 5-HT, including memory facilitation and the regulation of intestinal motility (Eglen et al., 
1995, Bockaert et al., 1997). Mice deficient in 5-HT4 receptors displayed abnormal stress-in-
duced feeding and locomotor behavior, which suggests that this receptor may serve as drug 
target in the treatment of eating disorders (Compan et al., 2004). Moreover, 5-HT4­receptors­
have been implicated in the pathogenesis of central and peripheral disorders such as neuro-
degenerative diseases, irritable bowel syndrome, and atrial fibrillation (Wong et al., 1996, 
De and Tonini, 2001, Callahan, 2002). Murine 5-HT4 receptors are coded by a complex gene 
that generates four carboxyl-terminal splice variants: 5-HT4(a), 5-HT4(b), 5-HT4(e), and 5-HT4(f)­
(Claeysen et al., 1999). Cloning of 5-HT4­homologs­from­human­and­rat­tissue­revealed­fur-
ther structural diversity of this receptor (Blondel et al., 1998). All of these receptor variants 
share the same sequence up to the common splicing site (Leu-358), followed by a unique C 
terminus. All splice variants were able to stimulate adenylyl cyclase and raise intracellular 
cAMP levels upon agonist stimulation (Blondel et al., 1998, Claeysen et al., 1999, Bender et 
al., 2000, Mialet et al., 2000a, Vilaro et al., 2002), albeit with different efficacy and potency 
(Mialet et al., 2000a,b). Differences may also extend to the type of G-proteins to which the 
various splice variants are coupled. For example, it was recently showed that the 5-HT4(a)­re-
ceptor is coupled to both Gαs­and­Gα13 proteins (Ponimaskin et al., 2002b), whereas the 5-
HT
4(b)
­isoform­activates­Gαi­and­Gαs proteins (Pindon et al., 2002). Moreover, 5-HT4­recep-
tor variants significantly differ in their sensitivity toward homologous agonist-induced de-
sensitization (Mialet et al., 2003). Together, these results indicate that the carboxyl terminus 
of the 5-HT4­receptor­plays­an­important­role­in­G-protein­coupling­as­well­as­in­the­initia-
tion­of­counter-regulatory­mechanisms.­
The 5-HT4 receptors contain potential sites for post-translational modifications with-
in their cytoplasmic carboxyl-terminal domains. It was showed previously that the 5-HT4(a)­
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receptor­is­palmitoylated­at­two­different­sites,­which­involves­a­conserved­cysteine­pair­
at amino acid positions 328/329 and an unusual additional site (Cys-386) near its C termi-
nus (Ponimaskin et al., 2002a). It was demonstrated that 5-HT
4(a)
­receptor­palmitoylation­is­
dynamically regulated upon agonist stimulation of the receptor (Ponimaskin et al., 2001). 
Common to many GPCRs, acylation of 5-HT4 receptors is believed to anchor their C-termi-
nal tails to the plasma membrane, thereby creating additional intracellular loops. 
The 5-HT5 receptor inhibits AC activit� via activation of the Gα
i/o 
protein First vari-
ant of the 5-HT5 receptor — 5-HT5A, is expressed in human, mouse and rat; while 5-HT5B 
was found in the same species except the human, where its coding sequence interrupted b� 
stop codon (Nelson 2004).  (Figure 1.5). Both receptor variants can be found in neurons of 
carotoid bod�, the function of these receptors is unknown (Barnes and Sharp 1999). 
The 5-HT6 receptor is positivel� coupled to AC via the Gα
S
 protein. It can be found 
in CNS regions such as olfactor� tubercules and hippocampus. Beside the brain, it’s also 
expressed in the stomach and the adrenal glands. The 5-HT6 receptor regulates cognition, 
feeding, and ma� be involved in glutamatergic and the cholinergic activit� of the neurons 
(Barnes and Sharp 1999).
The 5-HT7 receptors are encoded b� a single gene, which generate at least four dif-
ferent subt�pes b� alternative splicing. All isoforms are positivel� coupled to AC and in-
crease the cAMP formation via Gα
S 
protein (Barnes and Sharp 1999). Recentl� it was shown 
shown that Gα
12
 also can be activated b� the 5-HT7 receptor, this leads to the activation of 
small GTPases of the RhoA famil� (Kvachnina et al. 2005). The 5-HT7 receptors are ex-
pressed in the thalamus, the hippocampus, the h�pothalamus and the cortex of the brain; At 
the peripher� the� are expressed in the smooth muscles of the blood vessels and in the gas-
tro-intestinal tract. The 5-HT7 receptors are involved in control the circadian rh�thms and 
the sleep (Barnes and Sharp 1999).  
1.5	 Posttranslational	modifications	of	the	receptors
GPCRs often undergo different modifications after being translated. Those modifica-
tions pla� ver� important role in regulation of GPCR activities. The main t�pes of such post-
translational modifications include: 
 glycosylation, the addition of a gl�cos�l group to either asparagine, h�drox�l�sine, ser-
ine, or threonine, resulting in a gl�coprotein
 phosphorylation, the addition of a phosphate group, usuall� to serine, t�rosine, threo-
nine or histidine residues within the c�toplasmic receptor domains
 acylation, the addition of m�ristate or palmitate to one or several gl�cines or c�steines 
respectivel� to the N- or C- terminal of the protein (Figure 1.6)
 methylation, the addition of a meth�l group, usuall�, to l�sine or arginine residues. 
(This is a t�pe of alk�lation.)
i.
ii.
iii.
iv.
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In the present stud� we anal�sed role of ac�lation and possible interpla� between 
phosphor�lation and palmito�lation.
There are three classes of protein ac�lation in cells: S-palmito�lation, N-palmito�la-
tion and N-m�risto�lation. S-palmito�lation is the reversible addition of palmitate or other 
long fatt� acids to a protein at c�steine residues via a thioester linkage. N-palmito�lation oc-
curs on N-terminal c�steine residues with amide-linked palmitate. N-m�rostilation occurs 
co-translationaly on glycine residues and is a stable modification in many cases (Linder and 
Deschenes 2003). 
Since its discover� more than 30 �ears ago (Braun and Radin 1969), palmito�lation 
has been shown to pla� an important role in regulation of protein functions including pro-
tein-membrane interactions, trafficking, and enzyme activity. Up to now, two models of pal-
mito�lation: enz�matic and non-enz�matic are widel� accepted. 
1.5.1	 Mechanisms	of	palmitoylation
1.5.1.1 Nonenzymatic S-acylation
In 1987 O’Brien and coleagues (O’Brien et al. 1987). showed that rhodopsin might 
undergo spontaneous palmito�lation in a presence of palmito�l-CoA. It is still unclear wh� 
proteins undergo spontaneous palmitoylation, because there is no identifiable consensus se-
quence for palmito�lation. The best evidence for the regulator� role of spontaneous S-ac-
�lation was found in mitochondria. Bovine meth�lmalon�l semialdeh�de deh�drogenase 
(MMSDH) can be ac�lated b� an [125I]-labeled analogue of m�risto�l-CoA on an active site 
cysteine, resulting in enzyme inhibition. This finding together with evidence that palmito-
�l-CoA inhibits the activit� of several mitochondrial enz�mes suggests a regulator� role 
of S-ac�lation in metabolism (Linder et al. 1995, 1993, Mumb� 1997, Mumb� and Muntz 
1995, Mumb� et al. 1994).
1.5.1.2 Enzymatic palmitoylation
It is also known that palmito�lation can be an enz�matic process. Protein ac�l trans-
ferase (PAT) (enz�me, responsible for palmito�lation) has been detected in membrane 
fractions derived from a variet� of cell t�pes. It was also found in the Golgi (Linder and 
Deschenes 2003). Given the diverse nature of the palmito�lated proteins, it would not be 
surprising if there were multiple forms of protein acyl transferases. But it very difficult to 
perform extensive studies on this enz�me, due to its extremel� high instabilit�. Two t�pes 
of PATs were isolated from �east using the a genetic screening. Both groups reveal c�steine 
rich domains containing an Asp-His-His-C�s motif, which has been shown to be ver� criti-
cal for their function (Akgoz et al. 2002, Fukata et al. 2004, 2006, Linder et al. 1995, 1993). 
NH
O protein
C
C
CH2 protein
G
Myrostylation
Palmitoylation
Figure 1.6  Different types of acylation. Myristoylation is a stable cotranslational modification of 
gl�cine residue b� the saturated  m�ristic acid which is atached through . Palmito�lation occurs at 
the c�steine residues via the thioester-t�pe bond.
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1.5.1.3 Enzymatic depalmitoylation
Since S-palmito�lation is a reversible process, there should be a mechanism b� 
which attached palmityc acid can be removed. The finding that the rate of palmitate turnover 
exceeds that of the protein itself for man� palmito�lated substrates suggests that protein pal-
mito�lthioesterases, enz�mes involved in depalmito�lation are also present in the cell. Two 
enz�mes have been found and extensivel� characterized, a l�sosomal h�drox�lase, protein 
palmito�lthioesterase I (PPT I), and the c�toplasmic enz�me ac�lprotein palmito�lthioester-
ase I (APT I). L�sosomal localization of PPT I suggests its role in the palmito�lated protein 
catabolism, while c�toplasmic localization of APT I implies its role in palmitate turnover 
in the c�toplasm. It was also shown that APT I regulates the palmito�lation of Gα
s
 protein 
(Linder and Deschenes 2003). Recentl� it was also suggested that palmito�lation of the pro-
teins can be involved in disease processes in humans (Cho et al. 2000,Yanai et al. 2006).
1.5.2	 Palmitoylation	of	the	G-protein	coupled	receptors
It is known that proximatel� 80% of GPCRs contain conservative c�steine resi-
dues within their C-terminal c�toplasmic domain, which represent possible sites for pal-
mitoylation.  Palmitoylation has been also confirmed e�perimentally to several GPCRs. 
Analysis of acylation deficient mutants shows that there is no common acylation function 
applicable to all GPCRs (Qanbar and Bouvier 2003).  
Several recent studies have suggested that palmito�lation of GPCR ma� pla� a role 
in the processing and targeting of the protein. Initial protein palmito�lation occurs either 
in an ER-Golgi intermediate compartment, or in an earl� Golgi compartment (Charest and 
Bouvier 2003). In man� cases this palmito�lation appears to pla� an important role in the 
expression of functional receptors on the cell surface. For example, mutation of the palmi-
toylated cysteines within bovine opsin led to significant intracellular retention of the mutants 
when expressed in COS cells (Qanbar and Bouvier 2003). In some cases, such as the human 
thyrotropin receptor, delayed plasma membrane delivery of a palmitoylation-deficient mu-
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tant has been reported in the absence of measurable intracellular trapping. For some recep-
tors the lack of palmito�lated c�steines ma� also be accompanied b� accelerated degrada-
tion (Qanbar and Bouvier 2003). Whether these effects reflect a lack of palmitoylation in the 
receptor proteins or result from nonspecific conformational changes, leading to misfolding 
of the receptor, remains to be investigated.
For some GPCRs a d�namic agonist-dependent palmito�lation was shown (Daschem 
et al. 1992, Degt�arev et al. 1993, Kenned� and Limbird 1994, Ponimaskin et al., 2001). 
For example, stimulation of the receptor with agonist increases [3H]-palmitate incorpora-
tion in β2-adrenergic (Kenned� and Limbird 1994), 5-HT
4
 (Ponimaskin et al. 2001) and hu-
man delta opioid (Petaja-Repo et al. 2006) receptors. Previous studies suggested that pal-
mito�lation of the vasopressin receptor 2 (V2R) decreased upon stimulation (Sadeghi et al. 
1997, Schulein et al. 1996). However this was not confirmed in the recent studies (Charest 
and Bouvier 2003). 
 Several studies have suggested that, in addition to processing and targeting, palmito�-
lation ma� serve other roles that relate to the signaling function of GPCRs. For example, re-
cent studies on rhodopsin indicate that chemical depalmito�lation enhances light-dependent 
GTPase activit� of Gα
t
 and strongl� decreases the light-independent activit� of opsin-atr 
(Garnovska�a et al. 1996, Mulheron et al. 1994). Functional characterization of non-palmi-
to�lated β2-adrenergic and endothelin-B receptors has revealed that palmito�lation is essen-
tial for agonist-stimulated coupling to Gα
S
 and to both Gα
q
- and Gα
i
-proteins, respectivel� 
(Moffett et al. 1993, O’Dowd et al. 1989, Okamoto et al. 1998). Anal�sis of the non-pal-
mito�lated ETA receptor mutant demonstrated that ligand-induced stimulation of Gα
S
 was 
unaffected b� the lack of palmito�lation, whereas signalling through Gα
q
 was prevented 
(O’Dowd et al., 1989). In addition, recent data on chemokine CCR5 and prostac�clin recep-
tors also demonstrated that receptor palmitoylation is significantly involved in activation of 
intracellular signaling pathwa�s (Blanpain et al. 2001, Miggin et al. 2003). We have recentl� 
demonstrated that palmito�lation of the 5-HT
4(a)
 receptor modulates the agonist-independent 
constitutive receptor activit�. We demonstrated that mutation of the proximal palmito�lation 
site (Cys328/29-Ser) significantly increases the capacity of receptors to convert from the in-
active (R) to the active (R*) form in the absence of agonist. In contrast, the rate of isomeri-
zation from R to R* for the C�s386-Ser as well as for the triple, non-palmito�lated mutant 
(C�s328/29/86-Ser) was similar to that obtained for the wild-t�pe (Poniamskin et al. 2005). 
In addition, we have shown that the 5-HT1A receptor is stabl� palmito�lated at its C-termi-
nal cysteine residues Cys417 and Cys420. Characterization of acylation-deficient 5-HT1A 
mutants revealed that palmito�lation of the 5-HT1A receptor is critical for Gi-protein cou-
pling and effector signalling (Papoucheva et al. 2004). These findings show that receptor 
ac�lation pla�s differing functional roles at different receptor–G-protein interfaces, suggest-
ing that there is no common function applicable to all GPCRs. Therefore, an anal�sis of the 
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functions of palmito�lation is necessar� for each individual receptor in order to understand 
its signaling mechanism.
1.6 Aim of the study
 The main goal of this work was to stud� the role of palmito�lation of the 5-HT
4(a)
 
and 5-HT1A receptors for the receptor function. The following issues were anal�zed:
 5-HT
4(a)
 receptor
 mechanisms of the receptor phosphor�lation
 interpla� between ac�lation and phosphor�lation
 impact of palmito�lation on the receptor desensitization and internalization
 function of palmito�lation on the receptor–β-arrestin2 interaction (short term kinetic)
 role of G-protein receptor kinase 2 on the receptor–β-arrestin2 interaction
 
 5-HT1A receptor
 palmito�lation of the receptor and its function
 anal�sis of receptor localization with high spatial resolution
 role of microdomains in receptor signaling
 role of palmito�lation in receptor distirbution across the plasma membrane
i.
ii.
iii.
iv.
v.
i.
ii.
iii.
iv.
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2	 Materials	and	methods	
2.1 Chemicals 
Applied Biosystems: AmpliTaq Gold PCR Kit 
Amersham Biosciences: ECLTM Western Blot Detection Reagents, Nitrocellulose membrane, 
Blocking reagent 
Genomed: Jetsorb Gel Extraktion Kit 
Corning: 20 μm PVDF membranes mounted in 96-well microplates 
Hartmann Analytic GmbH: [3H]-GR11308 (30-60 Ci/mmol)
Invitrogen: Oligonucleotide primers, Lipofectamin 2000, TC-100 medium, DMEM-
Glutamax II medium, Geneticin, FCS (Fetal Calf Serum), Tr�psin, OptiMEM-1 medium 
S.O.C. medium, YT medium, Superscript RT-PCR kit 
Kodak: Kodak X-Omat AR film 
New England Biolabs: Enz�mes used in the molecular cloning 
Nunc: Cell culture plastic, white 96 well plates
PerkinElmer Life Sciences: DeepBlueC substrate
Promega: EnduRen substrate, SV Total RNA isolation s�stem, Wizard SV Genomic DNA 
purification system, Wizard SV Gel and PCR Clean-Up System, Coelenterazine H
Qiagen: Plasmid DNA purification Ma�i Kit, HiSpeed Plasmid Midi Kit 
Roth: Ammoniumpersulfat, Ampicillin (Potassium salt), TEMED, Acr�lamide, Bis-
Acr�lamide, 2-Merckaptoethanol, Gl�cine, X-gal, IPTG, kanam�cin, bromphenol blue
Sigma: 5-H�drox�tr�ptamine, F-12 HAM nutrient mixture, 8-OH-DPAT, Protein 
A-Sepharose CL-4B beads, Gentam�cin Sulfate, Kanam�cine Sulfate, SDS, 
Ethidiumbromide, Penicillin/Streptom�cin solution, PMSF, GDP, GTP, Bacto-Tr�ptone, 
Bacto-Yeast extract, Bacto-Agar, Total Protein Kit (Micro Lour�) for the protein concentra-
tion measurements
Molecular Probes: TertraSpeck microspheres 0,2 µm, fluorescent blue/green/red
2.2 Antibodies 
Abcam
Anti-GFP – rabbit polyclonal antibodies raised against a purified Green Fluorescent Protein 
(GFP) 
Santa Cruz Biotechnology
Anti-caveolin 1 – rabbit pol�clonal antibodies raised against the N-terminal peptide of 
caveolin  
Anti-CD71 – rabbit pol�clonal antibodies raised against the extracellular domain of the hu-
man transferrin receptor (CD71) 
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Anti-Caveolin 1 – mouse monoclonal antibodies 
New England Biolabs
p42/44 – rabbit pol�clonal antibodies raised against the mitogen-activated protein ki-
nase Erk 1/2
Anti–Rluc – rabbit pol�clonal antibodies against luciferase from Renilla reniformis
β-tubulin – mouse monoclonal antibodies against β-tubulin
CD71 – mouse monoclonal antibodies against transferrin receptor
2.3 Vectors 
Invitrogen: pcDNA3.1(–), pcDNA 3.1(+), pFastBac 
Clontech: pEGFP, pEYFP, pECFP
PerkinElmer: pRluc-N2, pβ-arrestin2–GFP2
2.4 Primers for 5-HT
4(a)
 cloning and sequencing
K1529E07 5’– GCT CAC TAG TCG CGG CCG CTT TC –3’
K1529E08 5’– GTA CGG TAC CAA AGC ATG ATT CCA GAG ACT –3’
K1529E09 5’– GTA CGG TAC CAA AGG ATG ATT CCA GAG ACT –3’
K4875G06 5’– CCC TGG ACA GGT ATT ACG CC –3’
K4875G05 5’– CCT TCT TGA ATA AGT CTT TC –3’
2.5 Solutions and buffers 
Assay buffer: 50 mM Tris-HCl, 5 mM MgCl
2
, 100 mM NaCl, pH 7.4
Blocking solution: 5% (w/v) ECL blocking reagent in PBS-Tween 
BRET2 assay buffer: CaCl
2
 (0.1 g/l), MgCl
2
×6H
2
O (0,1 g/l), D-Glucose (1g/l)
DeepBlueC stock I: 50 µg of substrate, 125 µl 100%. ethanol, final concentration 1 mM
DeepBlueC stock II: 1:20 DeepBlueC stock I in BRET2 assa� buffer, 5 μl per reaction
EnduRen stock I: vial of substrate resuspended in 10 μl of DMSO,
final concentration 60 mM
EnduRen stock II: 1:100 EnduRen stock I in cell culture medium,
final concetration 600 µM
HEPES-EDTA: 20 mM Hepes, 1 mM EDTA, pH 8.0 
Ligand binding buffer: 50 mM Tris (pH 7.7), 0.1 % ascorbic acid, 20 μM parg�line 
Ligation buffer: 50 mM Tris-HCl, 10 mM MgCl
2
, 10 mM DTT, 1 mM ATP, 
25 μg/ml BSA,  pH 7.5 
NTEP: 0.5% NP-40 (v/v), 150 mM NaCl, 50 mM Tris/HCl (pH 7.9), 5 mM EDTA, 10 mM 
iodinacetamide, 1mM PMSF, 0.1% SDS, pH 8.4 
P1 buffer: 50 mM Tris-HCl, 10 mM EDTA, 100 μg/ml RNAseA, pH 8.0 
P2 buffer: 200 mM NaOH, 1% SDS (w/v) 
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P3 buffer: 3 M CH
3
COONa, pH 5.0 
PBS: 140 mM NaCl, 3 mM KCl, 2 mM KH
2
PO
4
, pH 7.4 
PBS-Tween: PBS, 0.05 % (w/v) Tween 20 
PCR buffer: 20 mM Tris/HCl, 50 mM KCl, pH 8.4 
Protein electrophoresis separation buffer: 375 mM Tris-HCl, 3.5 mM SDS, pH 8.8 
TAE: 40 mM Tris, 1 mM EDTA, 20 mM acetic acid, pH 8.0 
TNE buffer: 25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 mM DTT, 10% su-
crose, 1% Triton X-100, 1 mM PMSF, 10 μM leupeptin, 2 μg/ml aprotinin 
Transfer buffer: 25 mM Tris/HCl, 192 mM gl�cine, 20% methanol, pH 8.3 
TE: 0.01 M Tris-HCl, (pH 7.6 or 7.4), 1 mM EDTA, pH 8.0 
Termination buffer: 50 mM Tris-HCl, 5 mM MgCl
2
, 100 mM NaCl, 0,5% NP-40, 1% 
aprotinin, 100 μM GDP, 100 μM GTP, pH 7.4
Protein electrophoresis stacking buffer: 125 mM Tris-HCl, 3.5 mM SDS, pH 6.8 
Protein loading buffer: 31 mM Tris/HCl, 10% Gl�cerin, 3% SDS,  
0.05 % bromphenolblue, pH 8.8 
QBT buffer: 750 mM NaCl, 50 mM MOPS, 15 % isopropanol, 0.15 %, 
Triton X-100, pH 7.0 
QC buffer: 1 M NaCl, 50 mM MOPS, 15 % isopropanol, pH 7.0 
QF buffer: 1,25 M NaCl, 50 mM Tris-HCl, 15 % isopropanol, pH 8.5 
Restriction buffer 1: 20 mM Tris-HCl, 10 mM MgCl
2
, 1 mM DTT, pH 7.0 
Restriction buffer 2: 50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl
2
, 1 mM DTT, pH 7.9
2.6 Recombinant DNA procedures
 The basic DNA procedures were performed as described b� Sambrook et al. 
(Sambrook et al. 1989). 
2.6.1	 Construction	of	5-HT
4(a)
–Rluc	fusion	protein
 The PCR primers were designed using the Vector NTI 10.0 software (InforMaxInc, 
1994–2005). Fragments were amplified from pFastBac–5-HT
4(a)
(Wt, C328/29→S, C386→
S, C328/29/86→S) vectors with primers K1529E07 and K1529E08 for 5-HT
4(a)
–Rluc wild 
t�pe; K1529E07 and K1559E09 for the p5-HT
4(a)
 C328/29→S, C386→S, C328/29/86→
S mutants under the following conditions: HotStart™ activation for 5 minutes at 94°C fol-
lowed by 35 cycles of amplification (94°C for 45 seconds – denaturation, 55°C for 56 sec-
onds – annealing, 72°C for 60 seconds – e�tension), final e�tension at 72°C for 5 minutes.
2.6.2	 Agarose	gel	electrophoresis	and	fragment	purification	
 The DNA fragments were separated b� agarose gel electrophoresis. The 1% agarose 
gels were prepared with TAE buffer and contained ethidium-bromide (EtBr) at final con-
centration of 0.5 μg/ml. After the separation DNA bands were visualized under ultraviolet 
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Figure 2.1 pRluc-N2 vector   map. 
5-HT
4(a)
 PCR fragment (1.2 kbp) was 
cloned into pRluc-N2 vector on KpnI–
EcoRI restriction sites of the pRluc-N2 
(5.4 kb) (MCS – multicloning site).
2Materials and Methods
light. Ethidium-bromide stained bands of DNA were e�cised from the gel and purified with 
the JetSorb DNA extraction kit or Wizard SV Gel and PCR Clean-Up S�stem according the 
manufacturer’s protocol.
2.6.3	 Preparation	of	PCR	products	for	cloning	
 Purified PCR product was treated with the restriction endonuclease KpnI and EcoRI 
to prepare the fragments with the “sticky” DNA ends for efficient cloning in the e�pression 
vector. The total volume of the reaction mixture was 50 μl. This mixture contained restric-
tion buffer 2, 100 µg/ml BSA, 1 mg of the purified PCR product and 1.5 units KpnI and 1 
units of EcoRI. The reaction was performed at 37ºC for 60 min. The DNA fragments were 
separated by agarose gel electrophoresis and purified by the JetSorb kit or Wizard SV Gel 
and PCR Clean-Up S�stem prior to the ligation. 
2.6.4	 Preparation	of	expression	vectors	for	cloning	
 Expression vector (pRluc-N2, PerkinElmer) was digested with the restriction endo-
nucleases KpnI and EcoRI as described above 
(Figure 2.1). After digestion, enz�mes was in-
activated b� incubation at 65°C for 20 min. 
“Stick�” ends of the digested expression vec-
tors were dephosphor�lated b� incubation with 
10 units of calf intestinal phosphatase to prevent 
self-ligation of the vector for 1 hour at 37°C. 
The digested and dephosphor�lated vectors were 
purified as described above. 
2.6.5	 Ligation	
  Ligation reactions were performed for 
2 hours at RT or for over night at +4ºC in 20 μl 
final volume and contained the ligation buffer, 
5 ng of the digested vector, 20-100 ng of the di-
gested PCR product and 8 units of T4 DNA li-
gase. The ligation mixture was used directl� for 
transformation of the DH5α competent cells. 
2.6.6	 Transformation
 The competent cells were thawed on ice and placed into 12-ml pol�prop�lene tubes. 
20 μl of the ligation mixture were added to 50 μl of competent cells and mixed. After incu-
bation for 30 minutes on ice, the cells were heat-shocked for 92 seconds at 37°C and placed 
on ice for 2 minutes, mixed with 800 μl of SOC medium and incubated for 1 hour at 37°C. 
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The cells were collected b� centrifugation and plated on the YT medium agar plates supple-
mented with appropriate selective antibiotics. The plates were incubated overnight at 37°C. 
2.6.7	 Analysis	of	the	clones	
 The bacterial colonies were collected with the sterile pipette tip and grown in 2 ml 
of the YT medium with the respective antibiotics b� overnight shaking at 37°C. The plas-
mid DNA was isolated from the overnight culture b� the alcaline l�sis method. The bacterial 
cells were centrifugated (1000x g for 5 minutes) and resuspended in 0.2 ml of the RNAse–
containing buffer P1. The cells were l�sed b� addition of an equal volume of the l�sis buffer 
P2 and incubated for 5 minutes at RT. The genomic DNA was then precipitated b� addition 
of 0.2 ml of the buffer P3 (pH 5.5). The precipitated genomic DNA was removed b� centrif-
ugation for 10 minutes at 20 000x g at 4°C. The plasmid DNA was precipitated from the su-
pernatant by addition of isopropanol to 45% final concentration and centrifuged for 10 min-
utes at 20 000x g, washed with 70% ethanol, air-dried and dissolved in 50 μl of TE buffer 
(pH 8.0). Orientation of the inserts was anal�zed b� digestion of the plasmid DNA with the 
restriction endonuclease BamHI. The reactions were performed in 50 μl at 37°C for 30 min-
utes. Each reaction mixture contained the restriction buffer 2, 500 ng of the DNA and 1U of 
the BamHI. The digestion products were anal�zed b� agarose gel electrophoresis.  
2.6.8	 Propagation	and	purification	of	the	plasmid	DNA
 The clones with the correct insert orientation were selected for plasmid amplifica-
tion. For that, 200 μl of the overnight culture was inoculated in 100 ml of the YT medium 
containing the respective antibiotic and incubated overnight under shaking at 37°C. The 
plasmid DNA was isolated using HiSpeed Plasmid Midi Kit (Qiagen). The plasmid DNA 
precipitate was washed with 70% ethanol, air-dried and diluted in 1 ml of TE (pH 8.0). The 
procedure yielded about 1 µg/µl of the pure plasmid DNA. The purified plasmid DNA was 
used for sequence anal�sis and for cell transfection. 
2.7 Cell culture and transfection 
2.7.1	 Culturing	of	the	Sf.9	insect	cells	
The Sf.9 cells were grown in 75-mm2 flasks in 10 ml of TC-100 medium supplemented with 
10% of FCS and 1% of penicillin-streptom�cin (PS) at 28°C. For sub-culturing, the medium 
was removed, the cells were scraped from the flask into 6 ml of fresh TC-100 medium, re-
suspended and one si�th of the suspension was transferred into the new flask. 
2.7.2	 Infection	of	the	Sf.9	cells	with	baculovirus	
 The Sf.9 cells (106 cells) were plated on 35 mm dishes one da� before the infection 
and incubated in a humid chamber at 28°C. Next da� the cells were infected with 105 plaque 
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forming units (pfu) of the purified baculovirus. The cells were incubated with the virus for 
60 min, being rocked ever� 15 minutes. After the incubation, the virus-containing medium 
was replaced b� TC-100 supplemented with 10% FCS and 1% PS. The cells were used for 
anal�sis 48 hours after the infection. 
2.7.3	 Culturing	of	the	mammalian	cells	
 The NIH-3T3 or HEK 293 cells were cultured in the DMEM medium supplement-
ed with GlutaMAX II, 10% of FCS and 1% of PS on 10 cm plates or in T-75 flasks. The 
CHO-K1 cells were cultured in the F-12 HAM medium supplemented with 10% of FCS and 
1% of PS. The N1E cells were cultured in the neurobasal medium supplemented with 10% 
of FCS and 1% of PS. For subculturing, the cells were treated with 3 ml of 0,05% (w/v) 
tr�psin /0.02% (w/v) EDTA, resuspended in 6 ml of the respective medium and 1/10 of the 
cell suspension was seeded on the new plate. HEK 293 cells were detached using a plastic 
scraper. All mammalian cells were grown at 37°C, 5% CO
2
 and 95% humidit� and medium 
was changed twice a week (Freshne� 2000).
2.7.4	 Transient	transfection	of	the	mammalian	cells	
 The cells (106 cells per dish) were plated on 35 mm dishes one da� before the trans-
fection. 10 μl of Lipofectamine 2000 were diluted in 250 μl of the OptiMEM-1 medium and 
incubated at RT for 5 minutes. 3 μg of the 5-HT
4(a)
–Rluc plasmid and 6 μg of β-arrestin2–
GFP2  were diluted in 250 μl of the OptiMEM medium and mixed with the Lipofectamine 
2000 solution. Mixture was incubated for 20 min at RT to form 
DNA/Lipofectamine complexes. After the incubation, 500 μl of the DNA/Lipofectamine 
2000 complexes were mixed with 1.5 ml of the culture medium containing 10% FCS and 
added to the cells for 8 hours and then replaced b� the culture medium with 10% FCS and 
1% PS. 
2.7.5	 Stable	transfection	of	the	mammalian	cells	
 The CHO-K1 cells were transfected using Lipofectamine 2000. One da� after the 
transfection, the cells were tr�psinized and 1/20 part of the cell suspension was plated on 
100 mm dishes. Twent� four hours after the split, the selective antibiotic Geneticin was 
added to the culturing media (DMEM, 10% FCS, 1% PS) at the final concentration of 1 mg/
ml. The concentration of Geneticin was adjusted b� dose-response anal�sis. The cells were 
grown in the selective medium for two weeks. During the incubation, the medium was ex-
changed ever� 3 da�s. Single colonies were collected b� the sterile pipette tip and plated 
on separate 100 mm dishes. The stabl� transfected cell lines were tested for the expression 
of the recombinant protein b� immunoblot anal�sis. The amount of the receptor surface ex-
pression was analyzed for the selected positive lines by specific radioligand binding. 
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2.8 Protein analysis 
2.8.1	 SDS-polyacrylamide	gel	electrophoresis	
 Twelve percent gels were used for the separation of proteins using SDS-pol�acr�l-
amide gel electrophoresis (SDS-PAGE). The proteins were solubilized in sample buffer, 
loaded on to the gel and separated by the application of electrical field. To define the protein 
size, a molecular weight marker was loaded in parallel.
2.8.2	 Immunoblot	
 After completion of the electrophoresis, gel was removed, pre-equilibrated in the 
transfer buffer (25 mM Tris/HCl, 192 mM gl�cine, 20% methanol, pH 8.3) and placed on 
top of the nitrocellulose membrane (0.2 µm pore diameter). Three sheets of Whatman filter 
paper pre-soaked in the transfer buffer were placed above and below the gel and the mem-
brane. Transfer of proteins to the membrane was performed b� application of 3 mA current 
per 1 cm2 for 2 hours. After the transfer, the membrane was incubated in blocking solution 
over night at 4°C on the rocking platform and incubated with the primar� antibodies dis-
solved in PBS/0.5% Tween for 1 hour at room temperature. The membranes were washed 3 
times for 20 minutes with PBS-Tween, incubated with the secondar� antibodies for 1 hour 
at room temperature, washed again and subjected to the detection. For protein detection, 
the chemiluminescent ECL Western Blotting Detection s�stem (Amersham Biosciences) 
was used. The protein bands were visualized b� exposure of nitrocellulose membrane to the 
Kodak-XOMAT AR films. 
2.8.3	 Phosphorylation	experiments	
 Spodoptera frugiperda (Sf.9) cells were infected with recombinant baculovirus en-
coding wild-t�pe or mutated 5-HT
4(a)
 receptors. Labeling experiments were started after 
48 hours of incubation. One hour before labeling, complete TC-100 was replaced b� phos-
phate-free TC-100 medium, and cells were labeled with 32P
i
 (Freedman et al. 1997) (150 
µCi/ml) for the time periods indicated in the figure legends. In some e�periments, 5-HT, 
forskolin, PMA, A23187, or staurosporin were added to final concentrations 10 µM, 50 
μM, 200 nM, 10 μM or 1 μM, respectivel�. After labeling, cells were washed twice with 
ice-cold PBS and lysed in 600 µl of NTEP buffer containing 10 mM sodium fluoride and 
10 mM disodium p�rophosphate. Insoluble material was pelleted (5 min at 15 000x g), and 
the antibod� AS9459 against the C-terminal domain of the 5-HT
4(a)
 receptor (Ponimaskin et 
al. 2001) was added to the supernatant together with 30 μl of protein A-Sepharose CL-4B. 
Samples were incubated under gentle rotation for 4 hours. After brief centrifugation, the pel-
let was washed three times with ice-cold buffer A, and the immunocomplexes were released 
from the beads b� incubation for 30 min at 37°C in nonreducing electrophoresis sample buf-
fer (62.5 mM Tris-HCl, pH 6.8, containing 20% gl�cerol, 6% SDS, and 0.002% bromphe-
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nol blue). Radiolabeled pol�peptides were anal�zed b� SDS-PAGE on 12% acr�lamide gels 
and visualized b� autoradiograph�. The expression of 5-HT
4(a)
 receptors was anal�zed in 
parallel b� immunoblot anal�sis with antibodies AS9459 at a 1:1000 dilution. The amount 
of [32P
i
]-phosphate incorporated into each of these mutants was then calculated b� autora-
diographic anal�sis in relation to the expression level of the various proteins as assessed b� 
densitometric anal�sis of immunoblots (Freedman et al. 1997).
2.8.4	 Phosphoamino	acid	analysis
 For the determination of phosphoamino acids, [32P
i
]-labeled Sf.9 cells (3x106 cells 
per 60-mm dish) expressing 5-HT
4(a)
 receptor wild-type or its acylation-deficient mutants 
were treated for 5 min with 10 μM 5-HT. Receptors were immunoprecipitated with the re-
ceptor-specific antibody AS9459 and resolved by SDS-PAGE on a 12% polyacrylamide 
gel. After electrophoretic transfer to a polyvinylidene difluoride membrane (Immobilon; 
Millipore Corporation (Bedford, MA) and autoradiograph�, receptors were excised and h�-
drol�zed in 6N HCl for 2 hours at 110°C. H�drol�sates were vacuum-dried, resolubilized in 
pH 1.9 buffer (formic acid/acetic acid/H
2
O, 10:100:1890 (v/v/v)) containing phosphoamino 
acid standards and spotted on a thin-la�er cellulose plate. Phosphoamino acids were sepa-
rated b� electrophoresis (900 V/1,5 h) at pH 1.9, followed b� a second electrophoresis (900 
V/45 min) at pH 3,5 (p�ridine/acetic acid/H
2
O, 10:100:1890 (v/v/v) and 0.5 mM EDTA) 
in the orthogonal direction. After ninh�drin staining of phosphoamino acid standards, thin-
layer plates were e�posed to autoradiographical screens and analyzed by filmless autoradio-
graphic anal�sis.
2.8.5	 Co-patching	assay
 For preparation of membrane sheets, stabl� transfected NIH-3T3 cells were treated 
according to  Avery et al. (Avery et al. 2000). Briefly, cells grown on coverslips were dis-
rupted b� 10 ms sonication in ice-cold KGlu buffer (120 mM K-glutamate, 20 mM K-ac-
etate, 20 mM HEPES pH 7.2). Co-patching of YFP-fused receptor and GM1 was carried 
out by simultaneous incubation of unfi�ed membrane sheets with goat anti-GFP antibody 
(Abcam; 1:1000 dilution) and cholera-toxin (Sigma, 1μg/ml). Incubation was performed 
in KGlu buffer containing 0.5% BSA for 60 min at 37°C. Membranes were washed and 
fi�ed in 4% PFA for 60 minutes. The fi�ed sheets were incubated with mouse anti-CTX an-
tibodies at 1:1000 dilution, followed b� incubation with Alexa Fluor 546-conjugated rab-   
bit anti-mouse antibod� (1:500). Before imaging, membranes were stained with TMA-
DPH, which was directl� added to the bath solution. For cholesterol depletion, membrane 
sheets were treated for 10 min with 5 mM meth�l-β-c�clodextrin (Sigma) in KGlu buffer    
prior co-patching procedure. For the line scan anal�sis, membrane sheets were imaged us-
ing Zeiss A�iovert 100 TV fluorescence microscope with a 100�1.4 NA Plan-Achromate 
objective and a back-illuminated frame transfer CCD-camera. Membrane sheets were im-
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aged in three channels, blue for TMA-DPH (430 nm), green for 5-HT1A-YFP (515 nm) 
and red for Alexa546-CTX (546 nm), whereas TMA-DPH staining was used to select intact         
membrane sheets for the anal�sis. Red and green channels were aligned b� color align func-         
tion of MetaMorph software (Universal Imaging, West Chester, PA, USA) using fluorescent          
beads (TetraSpec microspheres 0.2 μm, Molecular Probes) which have been added to ever�            
membrane preparation. For co-localization anal�sis, 20 lines (25 pixels/line) per image were 
drawn across clustered receptors, while red channel was switched off. Distance between red  
and green pixels at maximal intensit� was determined in each line on the merge pictures us-
ing line scan function of the MetaMorph software and when the distance was less than two 
pixels, a co-localization event was counted. For normalization, the counting protocol was re-
peated after horizontal flipping of the red channel.
2.8.6	 GTPγS	binding
 Agonist-promoted binding of [Eu]-GTPγS (Eu – Europium) to Gα protein was per-
formed according to the method described by Barr et al. (Barr et al. 1997). Briefly, 10 µg 
of membranes from transfected N1E cells were resuspended in 55 μl of 50 mM Tris-HCl 
(pH 7.4) containing 2 mM EDTA, 100 mM NaCl, 3 mM MgCl
2
, 1 μM GDP and 10 μM of 
agonist, and incubated at RT for 10 min. After adding [Eu]-GTPγS (PerkinElmer) to a final 
concentration of 10 nM samples were incubated for 1.5 hours at RT. The reaction was ter-
minated b� adding 600 μl of 50 mM Tris-HCl (pH 7.5) containing 20 mM MgCl
2
, 150 mM 
NaCl, 0.5% NP-40, 200 μg/ml aprotinin, 100 μM GDP and 100 μM GTP and incubated for 
15 min on the ice. The samples were incubated for 1.5 hours with 10 μl of antibod� raised 
against Gα
i3
 (SantaCruz) followed b� 1.5 hours at RT with 30 μl of Sepharose-Protein G 
(Sigma). Immunoprecipitates were washed three times, heated at 37°C for 15 min in 0.2 ml 
of 0.5% SDS, then centrifuged and supernatans were subjected to the fluorescense detection.
Fluorescence of [Eu]-GTPγS was measured at 615nm in fluorescent plate reader Mithras 
LB680 (Berthold) (Exitation 315 nm, emmision 615 nm).
2.8.7	 Immunocytochemistry	and	imaging
 Forty eight hours after the transfection, cells grown on coverslips were fi�ed with 
paraformaldeh�de (3% in PBS) for 15 min. The paraformaldeh�de was quenched with 50 
mM gl�cine for 15 min and the cells were washed three times with PBS. The cells were per-
meabilized with 0.1% Triton-X100 for 2 min and incubated for 1 hour with antibodies di-
luted in PBS containing 3% BSA. The secondar� antibodies were applied for 1 hour with 
subsequent washing in PBS. Finall�, coverslips were mounted mounting medium. The cells 
were imaged with the confocal laser-scaning microscope LSM510-Meta (Zeiss). All im-
age anal�sis and manipulations were done in Photoshop CS2, Illustrator CS2 (Adobe) and 
MetaMorph. 
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2.8.8	 BRET2	assay
 All BRET measurements were made in CHO or HEK 293 cells co-expressing 
5-HT
4(a)
–Rluc and β-arrestin2-GFP2 constructs. Fort� eight hours after transfection, cells 
were washed with PBS and resuspended in BRET assa� buffer at 37°C. Cells (approxi-
matel� 1x105 cells per well) were diluted in 40 μl of BRET assa� buffer and spread in white 
96 well plates (Nunc) and incubated in the presence or absence of 5-HT (added volume 
5 μl) for 2 min except in the case of the kinetical studies. Five microliters of DeepBlueC 
stock II (final concentration 5µM) were added, and readings were collected using Mithras 
LB650 (Berthold) under the control of MikroWin2000 software. The BRET signal was de-
termined b� calculating the ratio of the light emitted b� GFP2 (515 nm) over the light emit-
ted b� the Rluc (400 nm). The normalized BRET values were obtained b� subtracting the 
BRET background signal detected when 5-HT
4(a)
–Rluc construct was expressed alone. The 
expression level of the receptor was determined b� incubation of cells with CoelenterazineH 
(Promega) for 10 min at a final concentration of 5 µM, and the total luminescence of cells 
was measured. All BRET data was normalized to these values. In contrast to DeepBlueC, 
Coelenterazine, coelenterazine H does not lead to energ� transfer between Rluc and GFP2 
and thus allows evaluation of the receptor expression.
 For kinetic anal�sis of 5-HT
4(a)
 and β-arrestin2 interactions, EnduRen stock II solu-
tion was added before the injection of the 5-HT and the data were collected ever� 0.5 sec-
ond. Injection of the 5-HT was included within the kinetical program to allow baseline re-
cording followed by real-time recording of the BRET changes. Curves were fitted using a 
non-linear regression using GraphPad Prism software.
2.8.9	 Ligand	binding	experiments	
 The NIH 3T3 or CHO cells transfected with the receptor constructs were grown on 
24-well plates, starved in the respective medium without FCS for 16 hours prior to the as-
sa� and washed twice with ice-cold PBS. For the ligand binding, the cells were incubated 
with 50 nM [3H]-GR11308 diluted in culture medium containing 0.2 % BSA for 60 minutes 
on ice. The cells were washed 5 times with ice-cold PBS and l�sed in 0.2 M NaOH. The 
bound radioactivity was measured by the scintillation counter. Non-specific binding was de-
termined by the addition of 100 µM unlabeled 5-HT. The protocol is modified from Varrault 
and colleagues (Varrault et al. 1992).
   
 
 
BRET2 ratio= (eq. 1)- 5-HT
4(a)
–Rlucβ-arrestin2–GFP
2
5-HT
4(a)
–Rluc
q(t)=q(t→∞)+q(t=0)·e(-R)t (eq. 2)
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2.9 Data analysis
 For data anal�sis we used two different equations. First  equation was used to obtain 
raw data on receptor–β-arrestin2 interaction (Angers et al. 2000, Charest and Bouvier 2003). 
BRET data was represented as ratio between luminescence signal of β-arrestin2–GFP2, over 
luminescence of receptor–Renilla luciferase, minus luminescence of receptor–Renilla lucif-
erase expressed alone.
 To estimate half time of β-arrestin2 recruitment, linear part of the curve generated b� 
equation 2 was anal�zed (Charest and Bouvier 2003).  
Where t is the time of observation, R is the rate, and q represents the level of β-arrestin2 
recruitment.
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3	 Results
3.1 Role of the palmitoylation in 5-HT4(a) receptor functioning
3.1.1	 Phosphorylation	of	the	5-HT
4(a)
	receptor
 G-protein coupled receptors (GPCRs) often undergo agonist-induced phosphor�la-
tion, which is functionall� linked to receptor desensitization. Therefore we studied, wheth-
er the 5-HT
4(a)
 receptor is phosphor�lated upon agonist stimulation. For that recombinant 
5-HT
4(a)
 receptor was expressed in Sf.9 insect cells using baculovirus s�stem. Infected cells 
were incubated with [32P
i
] to label their ATP pool and then exposed to the 5-HT receptor ag-
onist 5-HT (10 μM, 10 min). After immunoprecipitation and SDS-PAGE, the receptor was 
anal�zed b� autoradiograph� as described in Materials and Methods. As shown in Figure 
3.1A, exposure of the receptor to 5-HT promoted the phosphor�lation of a single protein 
band with a molecular weight of approximatel� 42 kDa corresponding to the predicted mo-
lecular mass of the 5-HT
4
 receptor. This band co-migrated with the 5-HT
4(a)
 protein band de-
tected b� the immunoblot and was absent in noninfected, [32P
i
]-labeled control cells. To ex-
amine the dose dependence of 32P
i
 incorporation, Sf.9 cells expressing 5-HT
4(a)
 receptor were 
incubated in the presence of var�ing concentrations of 5-HT. Levels of radiolabel incorpora-
tion were then quantified by autoradiographic analysis after immunoprecipitation of 5-HT
4(a)
 
receptors and SDS-PAGE. Figure 3.1B demonstrates that 5-HT induced a dose dependent 
increase in the phosphor�lation intensit� of the receptor with an EC
50
 of 180 nM. Kinetic 
anal�sis revealed a rapid 5-HT-induced increase in 32P
i
 incorporation into the 5-HT
4(a)
 recep-
tor (τ
½
≈2 min), and ma�imal phosphorylation level was reached after 5 min (Figure  3.1C). 
Phosphor�lation of GPCRs ma� be controlled b� multiple second messenger-activated pro-
tein kinases, including protein kinase C, PKA, and calcium/calmodulin-dependent kinase. 
We investigated whether these protein kinases ma� participate in phosphor�lation of the 
5-HT
4(a)
 receptor. Treatment of [32P
i
]-labeled cells with forskolin, PMA, or with the Ca2+ ion-
ophore A23187 to stimulate PKA, PKC CaMK kinase respectivel�, however, did not induce 
increased receptor phosphor�lation (Figure 3.1A). Moreover, pretreatment of the receptor-
expressing cells with the protein kinase inhibitor staurosporin at 1 μM concentration did not 
reduce the agonist-promoted increase in 5-HT
4(a)
 receptor phosphor�lation (Figure 3.1D). 
This concentration is known to block all second messenger protein kinases. These results 
demonstrate that the second messenger-dependent kinases tested do not mediate 5-HT
4(a)
 re-
ceptor phosphor�lation. 
3.1.2	 Phosphorylation	of	palmitoylation-deficient	5-HT
4(a)
	receptor	
mutants
 We have recentl� shown that 5-HT
4(a)
 receptor undergoes agonist-dependent pal-
mito�lation and also localized the palmito�lation sites b� site-directed mutagenesis within 
5-HT, nM
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Figure 3.1 (A) 5-HT
4(a)
 receptor was expressed in Sf.9 insect cells, labeled with [32P
i
]phosphate and treated 
either with vehicle (H
2
O, control), 10 μM 5-HT, 50 μM forskolin, 200 nM PMA, or 10 μM A23187 for 10 
min. After immunoprecipitation with the antibod� AS9459 directed against C-terminal domain of the 5-HT
4(a)
 
receptor, samples were subjected to SDS-PAGE and autoradiograph�. Expression of the 5-HT
4(a)
 receptor 
was documented in parallel b� immunoblot (IB). (B) [32P
i
]-phosphate-labeled Sf.9 cells were treated with 
increasing concentrations of 5-HT for 10 min. Receptors were immunoprecipitated, and 32P
i
 incorporation was 
calculated after SDS-PAGE and autoradiograph�. The values represent the means±S.E.M. n=3 (C) Phosphor�-
lation kinetics were anal�zed in Sf.9 cells expressing the 5-HT
4(a)
 receptor. After labeling with [32P
i
]-phosphate, 
cells were treated with 10 μM 5-HT for the time interval shown and then subjected to immunoprecipitation, 
SDS-PAGE, and autoradiograph�. (D) Insect Sf.9 cells expressing recombinant 5-HT
4(a)
 receptor were labeled 
with [32P
i
]-phosphate and incubated with 1 μm of staurosporin for 20 min followed b� stimulation with 10 μM 
5-HT for 10 min. Expression of the 5-HT
4(a)
 receptor was determined in parallel b� immunoblot (IB).
A B
C D
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the receptor C-terminal c�toplasmic domain (Ponimaskin et al. 2001, 2002b). Because the 
5-HT
4(a)
 receptor undergoes agonist-induced phosphor�lation, we next anal�zed a possible 
interplay between these two post-translational receptor modifications. Sf.9 insect cells e�-
pressing either the wild-t�pe 5-HT
4(a)
 receptor or its palmitoylation- deficient mutants were 
loaded with 32P
i
, stimulated with 5-HT, and then subjected to immunoprecipitation, SDS-
PAGE, and autoradiograph�. Immunoblot anal�sis revealed that all mutants were expressed 
at levels comparable with those of the 5-HT
4(a)
 wild-t�pe control (Figure 3.2A), which al-
lows for a quantitative comparison of phosphor�lation levels in the different products. The 
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Figure 3.2 (A) Sf.9 cells expressing the 5-HT
4(a)
 receptor wild-type or its acylation-deficient mutants were 
incubated with either [32P
i
]-phosphate in the presence of either vehicle (H
2
O, control) or 10 μM 5-HT for 10 
min. Receptors were immunoprecipitated, resolved b� SDS-PAGE and anal�zed b� autoradiograph�. Expres-
sion of the 5-HT
4(a)
 receptor was anal�zed in parallel b� immunoblot (IB). (B) Changes in receptor phosphor�-
lation after 5-HT stimulation versus vehicle were determined b� autoradiographic anal�sis in relation to recep-
tor expression levels as determined b� immunoblot. Results are shown as mean percentage±S.E.M. (n=4). The 
value obtained for the receptor wild-type after 5-HT stimulation was set at 100%. A statistically significant  
difference between agonist-stimulated and nonstimulated phosphor�lation is indicated (*, p<0.01).
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amount of [32P
i
]-phosphate incorporated into each of these mutants was calculated b� densi-
tometry of fluorograms and normalized for e�pression levels of the various proteins as de-
termined b� immunoblotting. Anal�sis of the results obtained in 32P
i
 labeling experiments 
demonstrated that both basal and agonist-mediated phosphorylation efficiency for all acyla-
tion-deficient mutants was significantly elevated up to 2.7 fold compared with the wild-type 
receptor (Figure 3.2B). The increase in the phosphorylation efficiency over the basal level 
was particularl� pronounced in the case of C328/29-S and C386-S receptor mutants.   
3.1.2.1 Phosphoamino acid analysis
 The C-terminal domain of the 5-HT
4(a)
 receptor contains several serine and threonine 
residues that represent potential phosphate acceptor sites for G-protein receptor coupled 
GRK-mediated receptor phosphorylation. Therefore we defined which amino acids with-
in the 5-HT
4(a)
 receptor are modified by ligand-induced phosphorylation. We also analyzed 
Wt Cys328/29-Ser
Figure 3.3 Two-dimensional phosphoamino acid anal�sis of the 5-HT
4(a)
 receptor, Sf.9 insect cells ex-
pressing the 5-HT
4(a)
 receptor wild-t�pe or C�s328/329−Ser mutant were labeled with [32P
i
]-phosphate in the 
presence of 10 μM 5-HT. Phosphoamino acid anal�sis of the immunoprecipitated and h�drolized receptors 
was performed. Positions of phosphoserine (S), phosphothreonine (T), and phosphot�rosine (Y) were deter-
mined b� ninh�drin staining of phosphoamino acid standards, which were separated together with radioactive 
samples. 32P
i
 signal was located onl� in the area of the phosphoserine residues in both cases.
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whether different phosphorylation site(s) may be occupied in the acylation-deficient mu-
tants. Phosphoamino acid anal�sis performed b� 2D chromatograph� revealed that agonist-
mediated phosphorylation of the wild-type receptor as well as all acylation-deficient mutants 
occurs exclusivel� at serine residues (Figure 3.3).  
3.1.3	 β−arrestin2	mediated	desensitization	and	internalization	of	the	
5-HT
4(a)
	receptor
 To further assess the role of palmito�lation for the agonist-induced 5-HT
4(a)
 recep-
tor desensitization, the effects of sustained agonist treatment on the signaling efficacy of the 
Wt and acylation-deficient mutants were compared in COS-7 cells. Receptor activities were 
measured in transfected cells that were pretreated with or without 5-HT for different peri-
ods. Desensitization was then defined as the reduction in the efficiency of agonist to stimu-
late adenylate cyclase activity after agonist pretreatment. As illustrated in fi gure 3.4A, the 
onset of agonist-promoted desensitization was accelerated for all acylation-deficient mutants 
and particularl� for the C328/29-S construct, compared with wild-t�pe. However, the rate 
of desensitization was relativel� low; after 1 hour of preincubation, we found that the re-
sidual response to the agonist was 80±8%, 72±6%, 68±9%, and 62±7% for the Wt, C386-S, 
C328/29/86-S, and C328/29-S, respectivel�. Even at the longest desensitization time stud-
ied, we could still detect residual aden�late c�clase activit� of 62±6%, 50±5%, 45±8% and 
33±7% for the Wt, C386-S, C328/29/86-S, and C328/29-S, respectivel� (Figure 3.4B). This 
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Figure 3.4 Time course of desensitization of the 5-HT
4(a)
 receptor wild-type and palmitoylation deficient 
mutants. COS-7 cells e�pressing either the wild-type (wt) or acylation-deficient mutants were preincubated 
with 1 μM 5-HT for a short (0–60 min) (A) or for a long (0–18 h) (B) period of time. After extensive washes 
with the medium, cAMP accumulation was measured. Results are expressed as a percentage of residual 
stimulation relative to the maximal stimulation obtained for the particular receptor. Each value represents the 
means±S.E.M. from at least three independent e�periments performed in triplicate. Statistically significant dif-
ferences between receptor wild-t�pe and C�s328/329→Ser mutant after 1 h and 18 h are indicated.
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is in contrast to previous observations in rat esophagus and colliculus neurons of mouse, 
where exposure of cells to selective 5-HT
4(a)
 receptor agonists was accompanied b� a ver� 
potent and rapid desensitization of the receptor-stimulated aden�late c�clase response. Such 
divergent findings may either indicate cell type specific effects based on a differential e�-
pression of regulator� proteins or ma� result from overexpression of receptors in transfected 
cell lines. 
 Taken together, our results indicate that the acylation-deficient mutants were more 
sensitive to agonist pre-exposure than the receptor wild-t�pe. The rate of agonist-promot-
ed receptor desensitization was greatest for the proximal ac�lation mutant C328/29-S. This 
suggests that, in agreement with our findings with receptor phosphorylation, desensitization 
of the 5-HT
4(a)
 receptor ma� also be regulated b� its palmito�lation state (Ponimaskin et al. 
2005) (Desensitization experiments were done in collaboration with Dr. A Dumuis). 
3.1.3.1 Role of G-protein receptor kinase in desensitization of the 5-HT4(a) 
receptor 
Phosphor�lation of the 5-HT
4(a)
 receptor is not affected b� stimulation of several different 
second messenger-activated protein kinases (Figure 3.1A,D). In addition, it has been demon-
strated that the functional desensitization of the 5-HT
4
 receptors in mouse colliculus neurons 
is cAMP-independent and agonist-selective. This suggests a possible role of GRKs in the 
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Figure 3.5 Desensitization of the 5-HT
4(a)
 receptors after overexpression of GRK2. COS-7 cells expressing 
either the 5-HT
4(a)
 Wt receptor or acylation-deficient mutants were cotransfected with or without the vector 
encoding GRK2 (500 ng/107 cells). The 5-HT (10 μM) induced cAMP production was directl� measured 
during 10 min. Results are expressed as a percentage of the cAMP production in mock-transfected cells. In 
mock-transfected cells, 0,15±0,02% of [3H]-ATP was converted into [3H]-cAMP. The values are plotted as the 
percentage conversion of [3H]-ATP into [3H]-cAMP. Each value represents the means±S.E.M. n=3. A statisti-
cally significant difference between the values is indicated (*, p<0.01).
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desensitization process. To test this h�pothesis, we co-expressed GRK2 with the wild-t�pe 
and different 5-HT
4(a)
 receptor mutants and determined the amount of cAMP accumulation 
over a 10-min incubation period. In this experimental setting, “desensitization” is inter-
preted as the cumulative effect of GRK overexpression on 5-HT-induced cAMP generation 
compared with cells with endogenous GRK levels. As shown in Figure 3.5, the basal activ-
ity of cells co-e�pressing the different receptors together with GRK2 was not significantly 
changed. In contrast, the agonist-induced cyclase response was significantly (p<0.01) im-
paired in cells overexpressing GRK2 compared with the control (Figure 3.5). After a 10-min 
stimulation period with 5-HT, the maximal stimulation of aden�late c�clase in cells overex-
pressing GRK2 was reduced to 28±8%, 35±5%, 55±11%, and 51±9% of control cells (with-
out coexpression of GRK2) for the wild-t�pe, C328/29-S, C86-S, and C328/29/86-S, respec-
tivel�. A 60 min-agonist pre-exposure performed before the period of cAMP accumulation 
did not significantly decrease the 5-HT response (data not shown). Taken together, these re-
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sults strongl� suggest a role for GRK2 (or a related receptor kinase) in homologous desensi-
tization of the 5-HT
4(a)
 receptor.
3.1.3.2 Role of palmitoylation in agonist-induced internalization of the 
5-HT4(a) receptor
In man� GPCRs, GRK induced receptor phosphor�lation pla�s an important role in facili-
tating β-arrestin-mediated receptor internalization. To anal�ze whether the 5-HT
4(a)
 receptor 
undergoes agonist dependent internalization, the COS-7 cells were transientl� cotransfected 
with 5-HT
4(a)
–YFP receptor and β-arrestin2–GFP2. Functionalit� of receptor–YFP construct 
was confirmed by ligand binding, 5-HT induced adenylate cyclase activity, and serum re-
sponse element assa�. Distribution of the receptor and β-arrestin2 was then anal�zed b� con-
focal microscop� on LSM510-Meta microscope. Without agonist stimulation, the 5-HT
4(a)
 
receptor was mainl� localized at the plasma membrane, whereas β-arrestin2 showed homo-
geneous c�toplasmic staining (Figure 3.6A). Treatment of transfected cells with 1 μM 5-HT 
for 60 min induced clear receptor internalization with punctate, clustered 5-HT
4(a)
 recep-
tor–YFP structures that were partiall� colocalized with β-arrestin2 (Figure 3.6A). Having 
established that phosphorylation efficiency of the 5-HT
4(a)
 receptor is modulated b� receptor 
palmito�lation, we next compared the rate of agonist-mediated internalization for ac�lation-
deficient mutants. In addition, we analyzed whether arrestin might modulate this process. 
COS-7 cells were transientl� transfected with plasmids encoding the wild-t�pe or mutated 
receptors in the presence or absence of β-arrestin2 overexpression. Binding of the receptor-
specific antagonist [3H]-GR113808 on intact cells was used to quantif� the number of re-
ceptors at the cell surface. This assa� revealed that the wild-t�pe and all palmito�lation-de-
ficient mutants showed similar e�pression levels at the cell surface under basal conditions. 
Cells were then treated with the agonist, and internalization was measured up to 60 minutes 
after agonist exposure. As shown in the Figure 3.6B, in the absence of recombinant β-ar-
restin2 overe�pression, the wild-type and all acylation-deficient mutants underwent slow 
agonist-mediated internalization. We found that after 60 minutes of incubation with 5-HT, 
approximatel� 25% of the wild-t�pe, C386-S, and C328/29/86-S mutants were internal-
ized, whereas internalization of the pro�imal mutant C328/29-S was more efficient; appro�i-
matel� 35% of this mutant were removed from the cell surface (Figure 3.6). Co-expression 
of the 5-HT
4(a)
 receptor wild-t�pe with β-arrestin2 resulted onl� in moderate enhancement 
of internalization up to 30% (Figure 3.6C). In the case of the C386-S and C328/29/86-S mu-
tants, the rate of agonist-induced internalization upon coexpression with β-arrestin2 was in-
creased up to 45% (Figure 3.6C). The effect of β-arrestin2 overexpression was strongest in 
the C328/29-S mutant, where 77% of ligand binding sites were removed from the cell sur-
face after 60-min incubation with 5-HT (Figure 3.6D). The different effects of β-arrestin2 
overexpression on internalization of the receptor variants were found not to be caused b� 
different β-arrestin2 expression levels in the various transfections. The fact that the highest 
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Figure 3.6 (A) Internalization of the 5-HT
4(a)
 receptor and effect of β-arrestin2 overexpression. COS-7 cells 
expressing YFP-tagged 5-HT
4(a)
 receptor and GFP2-tagged β-arrestin2 were incubated for 1 hour with (lower 
panel) or without (upper panel) 1 µM 5-HT followed by fi�ation and microscopic analysis. Scale bar – 10 µM. 
(B–D) COS-7 cells were transiently transfected with vectors encoding WT or acylation-deficient mutants as 
indicated. The cells were stimulated with 1 μM 5-HT at 37°C and extensivel� washed. Sequestration of an-
tagonist [3H]-GR113808 from the cell surface was measured. Kinetics of internalization for the WT and indi-
cated acylation-deficient mutants in the absence (B) or presence (C) of β-arrestin2 overexpression are shown. 
(D) comparison of internalization kinetics for the Wt and C328/29-S mutant in the presence and absence of 
β-arrestin2 overe�pression. Data represent the means±S.E.M. from five independent e�periments performed 
in duplicate. A statistically significant difference between the values for the Wt and C328/29-S mutant in the 
presence of β-arrestin2 overexpression is indicated (*, p<0.01). Each value represents the means±S.E.M., n=3.
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rate of receptor endoc�tosis was obtained for the mutant C328/29-S suggests that the lack of 
palmito�lation at these sites renders 5-HT
4(a)
 receptors more susceptible to β-arrestin2-medi-
ated internalization, and this effect becomes more apparent under experimental conditions of 
β-arrestin2 overexpression. 
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Figure 3.7 (A) Schematic presentation of 5-HT
4(a)
–Rluc constructs. The part of C-terminal sequences includ-
ing mutated c�steins shown using single letter code. (B) HEK 293 cells were transfected with 5-HT
4(a)
–Rluc 
plasmids. Immunobloting revealed a band with molecular weight around 72kDa. (C) HEK 293 cells were 
transfected with the 5-HT
4(a)
Wt–Rluc, and its intracellular distribution was anal�zed b� confocal microscop� 
after treatments with TX-100 and immunostaining with anti-Rluc AB.
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3.1.3.3 BRET2 analysis of β-arrestin2 mediated desensitization of 5-HT4(a) 
receptor
3.1.3.3.1 Generation, expression and functional properties of the 5-HT
4(a)
–Rluc 
constructs
 To stud� the impact of the palmito�lation on the 5-HT
4(a)
 receptor desensitization 
b� BRET2 assa�. 5-HT
4(a)
–Rluc fusion constructs were generated b� PCR using primers 
K1529E07 and  K1529E08 for the the 5-HT
4(a)
Wt–Rluc; K1529E07 and K1529E09 for the 
5-HT
4(a) 
C328/29-S; C386-S; C328/29/86-S–Rluc. Generated PCR products were subcloned 
into pRluc-N2 vector, and sequenced with K4875G06 primer to check the presence of the 
mutated c�steine residues and K4875G05 to ensure the correct reading frame. Attachment 
of the Renilla luciferase (36 kDa) to the 5-HT
4(a)
 receptor will cause an increase in molecular 
weight of the receptor from 43 kDa to 79 kDa. Immunoblot anal�sis made from transfected 
HEK 293 cells discovered a single protein band with a predicted molecular weight of ap-
proximatel� 76 kDa for the wild-t�pe and all mutants. Transfected cells were also subjected 
to immunofluorescence microscopy with anti-Renilla luciferase antibodies (Figure 3.7C). 
Anal�zis of subcellular distribution performed b� confocal microscop� after immunoc�to-
chemistr� revealed that the major fraction of the receptors fused to Rluc possesses the simi-
lar intracellular distribution as its non-fused counterpart.
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Figure 3.8 Pharmacological properties of the chimeric receptors, HEK 293 cells were transfected with dif-
ferent variants of the 5-HT
4(a)
–Rluc plasmid and binding properties were analyzed with a specific antagonist of 
the 5-HT
4(a)
 receptor — [3H]-GR113808. Each value represents the mean±S.E. n=3.
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3.1.3.3.2 Pharmacological properties of 5-HT
4(a)
–Rluc constructs
 To confirm that attachment of Renilla luciferase does not affect pharmacological 
properties of the receptor. Receptor–Rluc constructs were subjected to a pharmacological 
analysis with a specific antagonist of the 5-HT
4(a)
 receptor — [3H]-GR113808. The binding 
affinities of [3H]-GR113808 for all 5-HT
4(a)
–Rluc constructs were similar to that observed 
for the non-labled receptor. These values are also in accordance with previous data, demon-
strating that the YFP fusion does not change the pharmacological properties of the wild-t�pe 
5-HT
4(a)
 receptor. In addition, binding affinity obtained for all acylation-deficient mutants 
fused to luciferase and was similar to results published before (Ponimaskin et al. 2002) 
(Figure 3.8).
3.1.3.3.3 Analysis of receptor expression level by using  Renilla luciferase 
luminescence
 To exclude the problem of variation in expression level from trial to trial, we per-
formed a normalization assa�, where we normalized BRET2 data to the level of 5-HT
4(a)
–
Rluc receptor expression. Standard technique to measure receptor expression level in differ-
ent e�periments is a radioligand-binding assay. But it is difficult to perform this assay in par-
allel with BRET2 experiment. In addition this experiments need a radioactive substances and 
are ver� time consuming. Therefore we examine wether data obtained b� radioligand-bind-
ing assa� ma� correlate with the measurement of the luciferase luminescence. To establish 
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Figure 3.9 To normalize BRET2 data to the expression level of the 5-HT
4(a)
–Rluc, luminescence level of 
the Renilla luciferase was correlated to the amount of the receptor on the cell surface (in range from 250 to 
1500 fmol/mg), which was measured b� ligand binding. Linear dependence between the luminescence and the 
amount of the receptor was noted. Each value represents the mean±S.E. n=3.
Wt C328/29–S C386–S C328/29/86–S
KD (x10
-9 M) 0,25±0,05 0,84±0,11 0,33±0,09 0,40±0,04
Table 1. Binding of the [3H]-GR113808 to the Rluc-tagged 5-HT4(a) receptor wild-type and acylation defi-
cient mutants. Binding was perform in HEK 293 cells transiently expressing different forms of the 5-HT4(a)­
receptor. K
D
 values calculated from three independent experiments and each value represents the ­
mean±S.E. n=3. Data were analyzed by GraphPad Prism software.
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this new assa� we transfected HEK 293 cells with 5-HT
4(a)
–Rluc construct and anal�zed the 
expression of the receptor b� measuring luminescence after addition of the Colenterazine H 
substrate. In parallel, the radioligand-binding assa� was done. Figure 3.9 shows that there is 
a linear dependence between expression level of the receptor-luciferase fusion protein as as-
sessed b� radiligand binding and luminescence. It is noteworth� that using Coelenterazine H 
as substrate; does not promote energ� transfer to GFP2. Anal�sis of receptor expression b� 
using Coelenterazine H luminescence was then applied in ever� BRET experiment and to 
the some expression level. 
3.1.3.3.4 Establishing of the BRET2 assay
 To stud� direct interaction between β-arrestin2 and 5-HT
4(a)
 receptor, we utilized 
Bioluminescent Resonance Energ� Transfer (BRET2) assa�. This approach is based on 
Förster energ� transfer between Renilla reniformis’ luciferase and GFP2. It is similar to 
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Figure 3.10 BRET2 control experiments. HEK 293 cells were transfected either with the pRluc–GFP2 fusion 
construct, with Rluc alone or co-transfected with Rluc and GFP2 as negative controls. Rluc–GFP2 plasmid 
caused more that 30 fold increase in BRET ratio in comparison with negative controls. A statistically signifi-
cant difference between the values is indicated (**, p>0.01). Each value represents the mean±S.E. n=3.
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FRET principle, but does not have some disadvantages of the last one. In BRET there is no 
need of an external source of illumination to excite the donor, because this is promoted b� 
enz�matic oxidation of the cell-permeable substrate. This drasticall� reduces background 
noise during BRET2 measurements. In addition no spectral overlaping of emissions spec-
tras. To establish this assa�, we performed control experiments, where HEK 293 cells were 
transfected with a vector coding fusion protein between Renilla luciferase and GFP2 (BRET2 
controls) or co-transfected with Renilla luciferase and GFP2 coding plasmids (Figure 3.10). 
BRET efficiency of the fusion protein was close to 1, and both negative controls showed 
extremel� low values around 0,03±0,005. This result demonstrated high reproducibilit� of 
BRET signal and that BRET2 assa� characterized b�  a ver� good signal to noise ratio.
3.1.3.3.5 Dose dependence of receptor–β-arrestin2 interaction by BRET2 assay
 To anal�ze interaction between 5-HT
4
 receptor and β-arrestin2 in living cells, we 
measured BRET response in HEK 293 cells, co-expressing receptor-luciferase and β-arres-
tin2–GFP2 constructs. For that, cells were treated with serotonin in range from 10-9 M to 10-5 
M (Figure 3.11). Concentration of 10 μM of 5-HT was chosen for further experiments, since 
at this concentration increase in BRET ratio was maximal for wild-t�pe and C328/29-S re-
ceptors (around 30%). We also applied frequency distribution analysis to study the specific-
it� of increase of the BRET2 signal after application of serotonin (Figure 3.12). This anal�sis 
revealed a shift to the right (higher BRET2 values) after agonist application indicating recep-
tor–β-arrestin2 interaction.
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Figure 3.11 HEK 293 cells solel� expressing wild-t�pe or co-expressing 5-HT4(a)-Rluc wild-t�pe or 
C�s328/29-Ser and β-arrestin2–GFP2 constructs were treated with increasing concentrations (0 M to 3,16x10-
5 M) of 5-HT for 60 seconds, then BRET measurement was performed. A statistically significant difference 
between the values is indicated with * (p>0,05). Each value represents the mean±S.E. n=3.
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3.1.3.3.6 Time course analysis of 5-HT
4(a)
 and β-arrestin2 interaction
 The general sequence of the events involved in receptor desensitization is well un-
derstood. However, since man� biochemical assa�s onl� allow measuring responses onl� 
within minutes and even hours, it is still unknown what is happen immediatel� after recep-
tor activation. To anal�ze receptor–β-arrestin2 interaction with millisecond resolution we 
applied modification of the BRET2 assa� published b� Bouvier’s group (Gales et al. 2005). 
This assa� time resolved anal�sis b� measuring of BRET ever� 50 miliseconds (Figure 
3.13A). For data fitting we applied equation 1 (Figure 3.13B) (Charest and Bouvier 2003). 
From this anal�sis half speed of the β-arrestin2 recruitment to the receptor (τ
½
) was calculat-
ed for the wild-t�pe and mutants (Table 2). 
 All three mutants demonstrated a higher level of interaction prior to stimulation 
with BRET values of  0.145±0.004, 0.142±0.003, 0.140±0.002 for C328/29-S, C386-S 
and C328/29/86-S respectivel�. in comparison with the wild-t�pe 0.130±0.003 (Figure 
3.15). However, maximal BRET ratios obtained upon stimulation for the ac�lation mutant 
0.198±0.001, 0.194±0.001, 0.193±0.001,  C328/29-S, C386-S and C328/29/86-S respective-
l�, did not reach  0.207±0.001 values for the wild-t�pe (Figure 3.15). This means that maxi-
mal increase in interaction was obtained for the wild-t�pe (1.59 fold) while this values for 
acylation-deficient mutants was reduced to 1.36. Interaction kinetic was also different. For 
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Figure 3.13  (A) Short term kinetic of the 5-HT
4(a)
 receptor and ß-arrestin2 interaction was measured in 
HEK 293 cell co-expressing with the 5-HT
4(a)
–Rluc and β-arrestin2–GFP2 constructs, and BRET ratio was 
calculated every 50 milliseconds. After 20 seconds starting the measurement 10 µM (final conc.) of 5-HT was 
added to the cells and BRET measurements were continued for another 80 seconds. (B) To anal�ze the speed 
of interaction, e�ponential fitting eq. 2 was applied to the raw data from graph A.
Wt Cys328/29-Ser Cys386-Ser Cys328/29/86-Ser
τ½
— 10,31±1,12 12,12±2,98 19,22±2,08 21,19±1,77
GRK2 Wt 10,21±1,88 12,11±2,96 19,20±2,07 21,19±1,76
GRK2 DNM 10,31±1,12 12,12±2,98 19,22±2,08 21,19±1,77
Table 2. Half time of 5-HT
4(a)
 receptor–β-arrestin2 interaction was calculated in presence or absence of the 
GRK2 wild-t�pe or dominant negative mutant
Wt
0
10
20
30
40
BRET 2 ratio
Cys328/29-Ser
0
10
20
30
40
BRET 2 ratio
Cys386-Ser
0
10
20
30
40
BRET 2 ratio
Cys328/29/86-Ser
0
10
20
30
BRET 2 ratio
– 5-HT – H2O%
Figure 3.12 Frequency distribution analysis of BRET ratio. To proof that increase in BRET ratio is specific 
and caused b� stimulation of the 5-HT
4(a)
 rceptor with 5-HT. Two distinct peaks in distribution of the BRET 
values demonstrate a shift in BRET values after serotonin application.
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Figure 3.14 Role of GRK2 in 5-HT
4(a)
 receptor desensitization was studied in HEK 293 cells, which were 
co-transfected with the wild-t�pe GRK2 or dominant negative mutant form (GRK2 DNM). Wild-t�pe (A) and  
acylation-deficient mutants (B,C,D) of the 5-HT
4(a)
 receptor were anal�zed. Overexpression of wild-t�pe form 
of the GRK2 promotes coupling of β-arrestin2 to the 5-HT
4(a)
 receptor before and after agonist stimulation. 
Dominant negative form of the GRK2 also promotes β-arrestin2 and 5-HT
4(a)
 receptor interaction but less ef-
ficiently than that for the wild-type GRK2.
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the wild-t�pe the τ
½
 values was 10.31±1.12 and 12.12±2.98, 19.22±2.98, 21.19±1.77 sec-
onds (Figure 3.13, Table 2) demonstrating that the interaction  rate was slower in case of ac-
ylation-deficient mutants.  
3.1.3.3.7 Role of G-protein receptor kinase in receptor–β-arestin2 interaction
 It is known that GRK2 is criticall� involved in the GPCRs desensitization, serving as 
an enz�me for receptor phosphor�lation, and also ma� act as an adaptor protein (Oppermann 
et al. 1996, Tesmer et al., 2005). In our stud�, we obtained that overexpression of GRK2 
significantly promotes β-arrestin2 recruitment to the wild-t�pe receptor and palmito�lation 
deficient mutants both with and without stimulation of the receptor by agonist (Figure 3.14, 
Figure 3.15). However, overexpression of GRK2 did not affect the interaction kinetic (τ
½
) 
was not changed upon GRK2 overexpression (Table 2). Interestingl�, overexpression of 
GRK2 dominant negative mutant did not abolish recruitment of β-arrestin2 to the receptor, 
as one could expect based on the lack of enz�matic activit� b� GRK2 dominant negative 
mutant. Effect was slightl� smaller as a full� functional GRK2 (Figure 3.14, Figure 3.15). 
This might be explained b� the fact that the wild-t�pe form of GRK2 has two wa�s of in-
teraction with the receptor. (i) when GRK2 phosphor�late the receptor on serine/threonine 
residues and b� this receptor became susceptible for β-arrestin mediated desensitization. (ii) 
GRK2 ma� bind directl� to the receptor and serve as an adaptor protein for facilitating the 
desensetization of the receptor (Oppermann et al. 1996, Tesmer et al. 2005).
3.2 Role of palmitoylation in 5-HT1A receptor localization
3.2.1	 Generation	and	functional	properties	of	5-HT1A–YFP	fusion	
constructs
 We have previousl� demonstrated that 5-HT1A receptor has a stable palmito�lation 
(Papoucheva et al. 2004), but the role of palmitoylation in receptor trafficking is remained 
unlcear. Therefore, we anal�zed the function of palmito�lation in receptor–lipid rafts com-
munication.  To stud� 5-HT1A receptor-mediated signalling processes in living cells, en-
hanced yellow fluorescence protein (YFP) was fused to the C-terminal domain of the wild-
type (Wt-YFP) and acylation-deficient (DM-YFP) 5-HT1A receptors after removing the 
stop codon (Figure 3.16A). Immunoblot anal�sis performed in transfected neuroblastoma 
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Figure 3.15 GRK2 wild-t�pe or dominant negative mutant was co-expressed with 5-HT
4(a)
 wild-t�pe or 
acylation deficient mutant and β-arrestin2, and BRET2 was measured in the presence or absence of 5-HT. Each 
value represents the mean±S.E. n=3.
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N1E-115 cells revealed a protein band with a predicted molecular weight of approximatel� 
76 kDa for both Wt-YFP and DM-YFP constructs (Figure 3.16B). 
 To exclude the possibilit� that fusion to the YFP alters receptor properties, we an-
alyzed the subcellular distribution, pharmacological profile as well as downstream sig-
nalling of the fluorescent-labelled receptors by comparison with the 5-HT1A–HA recep-
tors (Papoucheva et al. 2004). Confocal microscop� performed after transient transfection 
of Wt-YFP or DM-YFP constructs into N1E-115 cells revealed that the major part of the 
YFP-tagged receptors was on the plasma membranes with onl� a minor fraction present in 
the intracellular compartments (Figure 3.16C). 
 The pharmacological profiles of the Wt-YFP and DM-YFP constructs were analyzed 
b� saturation binding of the selective 5-HT1A receptor agonist [3H]-8-OH DPAT in the 
membrane preparations from transfected NIH-3T3 cells (Figure 3.17). The binding affini-
ties of [3H]-8-OH DPAT for Wt-YFP (K
D
=0.72±0.53 nM) and DM-YFP (K
D
=0,97±0,26 nM) 
were similar to that obtained for the HA-tagged receptors (K
D
=0,76±0,23 nM). These values 
are also in accordance with those previousl� reported (Pucad�il et al. 2004), demonstrating 
that the YFP fusion does not change the pharmacological properties of the 5-HT1A receptor. 
(Cloning were done b� Dr. E. Papoucheva, microscop�  and ligand binding was performed 
b� Dr. U. Renner)
 Along with the microscop� anal�sis and pharmacological examination we anal�zed 
Figure 3.17 Saturation binding analysis. The plots represent specific binding of agonist [3H]-8 OH-DPAT 
to Wt-YFP, DM-YFP and HA-Wt.  Radioligand binding assa� was performed on membranes prepared from 
transfected NIH-3T3 cells. Data were fitted using the one-site saturation binding model and data points repre-
sent the means±S.E. from at least three independent experiments.
Figure 3.16 Construction and expression of the 5-HT1A–YFP receptors. (A) Schematic presentation of 
the wild-type and acylation deficient 5-HT1A receptors fused C-terminally with yellow fluorescent protein to 
produce Wt-YFP and DM-YFP constructs, respectivel�. C-terminal amino acid sequence of the 5-HT1A recep-
tor is shown with a single letter code. (B) Immunoblot anal�sis of YFP- and HA-tagged 5-HT1A receptors 
transientl� expressed in N1E-115 cells. The blots were probed with antibodies directed against GFP or HA-tag. 
The molecular weight marker is indicated between the panels. (C) Intracellular distribution of Wt-YFP and 
DM-YFP constructs. Representative confocal images obtained with LSM510-Meta microscope at 63� magnifi-
cation are shown. Scale bar, 10 μM. (from manuscript Renner, Glebov et al. submitted to Mol. Pharmacol.)
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Figure 3.18 The ability of diffirent tagged receptors to stimulate Gα
i3
 after application of agonist (10 μM) 
was analysed, for 5-HT1A–HA, 5-HT1A-YFP wild-type or acylation deficient mutants. Binding of [Eu]-GT-
PγS to the Gα
i3
 subunit was anal�sed asdescribed in materials and methods.  Data represented as mean±S.E. 
(**, p<0,05; ***, p<0,01) n=2. 
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signaling efficacy of YFP fused receptors by new [Eu]-GTPγS binding assa�. This assa� is 
based on fluorescent labeled GTPγS and does not need radioactive [36S]-GTPγS. N1E 115 
cells were transfected with HA–5-HT1A (as a positive control) or 5-HT1A–YFP wild-t�pe 
or acylation-deficient . The HA-tagged and YFP-tagged 5-HT1A receptor wild-type were 
capable to activate Gα
i3
-protein, where the acylation-deficient form of the 5-HT1A complete 
lacked this abilit� (Figure 3.18). This data correlates with our previous observations done b� 
Papoucheva et al. (Papoucheva et al. 2004). (Renner U, Glebov K. et al., manuscript submit-
ted to Molecular Pharmacolog�).
3.2.2	 Distribution	of	wild-type	and	palmitoylation-deficient	5-HT1A	re-
ceptors	within	membrane	subdomains	
 Lipid modifications have been shown to play a role in the partitioning of several 
proteins into defined membrane subdomains, like lipid rafts and caveolae (Arni et al. 1998, 
Melkonian et al. 1999, Moffett et al. 2000). To determine, whether this ma� be the case for 
the 5-HT1A receptor, we compared the membrane distribution of the wild-t�pe receptor and 
acylation-deficient mutant using density gradient centrifugation.  Immunoblot analysis of 
gradient fractions revealed that 33±11% (n=4) of the wild-t�pe 5-HT1A and to 4±3% (n=4) 
of the 5-HT1A receptor floated with the detergent-resistant low-density fractions along 
with the caveolae-specific protein caveolin-1 and the Gα
i3
-subunit of heterotrimeric G-pro-
tein (Figure 3.19). It is also notable that distribution of the raft- as well as non-raft markers 
did not change in cell expressing DM-YFP, when compared to the corresponding fractions 
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Figure 3.19 The NIH-3T3 cells stabl� expressing either the 5-HT1A–YFP Wt or the 5-HT1A–YFP double 
mutant were l�sed with the cold 1% Triton-X100 and l�sates were ultracentrifugated in the OptiprepTM den-
sit� gradient. The gradient fractions were anal�sed b� immunoblotting. Relative amount of the receptor in the 
high density fractions (35%+40%) and the buoyant low density fractions (25%+30%). A statistically signifi-
cant difference between values is noted (*, p<0,05).
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generated from the Wt-YFP expressing cells (Figure 3.19). This result suggests that palmi-
to�lation represents a targeting signal responsible for the partial localization of the 5-HT1A 
receptor in lipid rafts. This assumption was further supported b� the observation that the 
pre-treatment of cells with meth�l-β-cyclode�trin (MßCD) significantly reduced the amount 
of Wt-YFP receptor and Gα
i3
-subunit in the low densit� fractions (not shown, Renner U., 
Glebov K. et al., manuscript submitted to Molecular Pharmacolog�). The cholesterol bind-
ing agent MßCD was previousl� shown to disrupt the cholesterol-enriched membrane 
subdomains b� depletion of cholesterol from the plasma membrane (Harder et al. 1998). 
(Renner U., Glebov K. et al., manuscript submitted to Mol. Pharmacol.)
 Gradient centrifugation after solubilization with cold TX-100 is a classical wa� to 
stud� subcellular distribution of proteins in lipid rafts. To verif� these results, we applied 
fluorescence microscopy techniques to analyze the association of 5-HT1A receptor with 
lipid rafts on native plasma membrane sheets b� using a copatching assa� (Harder et al. 
1998). Membrane sheets from the cells stabl� expressing the wild-t�pe or double mutant 
of 5-HT1A receptor, were prepared b� a brief ultrasound pulse, leaving behind the basal 
plasma membrane attached to the glass coverslip (Lang et al. 2001). After fi�ation of mem-
brane sheets, lipid rafts were visualized b� the treatment with the cholera toxin (CTX), 
which binds to the raft-associated ganglioside GM1. As shown in Figure 3.20, both GM1 
and 5-HT1A-YFP receptor signals were highl� abundant and relative homogenous, thus not 
allowing to differentiate between specific and random colocalization. Therefore, segrega-
tion of the lipid rafts and receptors in more distinct domains was induced b� incubating the 
native versus fi�ed membrane sheets with low concentrations of CTX and an anti-GFP an-
tibod�, respectivel�, in order to crosslink the corresponding domains (Spiegel et al. 1984). 
Membrane
(TMA-DPH)
5-HT1A
(YFP)
Lipid rafts
(GM1/CTX) Merge
5-
HT
1A
W
t
(d
ire
ct 
fix
at
ion
)
A
B C
5-
HT
1A
W
t
5-
HT
1A
DM
5-
HT
1A
W
t
(M
βD
 tr
ea
tm
en
t)
a aʼ
b bʼ
b bʼ
a aʼ
5Results
Figure 3.20 (A) Co-patching assa� was performed in plasma membrane sheets derived from the stabl� 
transfected NIH-3T3 cells. Staining of the membrane lipids with TMA-DPH (blue). Co-patching of 5-HT1A-
YFP receptors with anti-GFP antibod� (green). Co-patching of GM1 with cholera toxin. GM1 patches were de-
tected using Alexa546 anti-CTX antibod� (red). Membrane sheets were fi�ed before incubation with anti-GFP 
antibod� and CTX. (direct fixation). Distribution of Wt-YFP and ganglioside GM1 after cholesterol depletion 
with meth�l-β-c�clodextran (MβD treatment). Both experiments served as negative controls. Membrane sheets 
were fi�ed after incubation with anti-GFP antibody and CTX (5-HT1A
Wt
 and 5-HT1A
DM
). Circles mark the 
fluorescent beads which were used to align images obtained in different fluorescence channels for quantitative 
anal�sis. (B) Distribution of 5-HT1A
Wt
 (a) and lipid rafts marker GM1/CTX (a’) in the membrane sheets in the 
absence of the crosslinking reagents. And after co-patching procedure, 5-HT1A
DM
 (b) and GM1/CTX (b’) . (C) 
Example of the line scans anal�sis for regions 1 and 2, which are shown with arrows in (A, 5-HT1A
DM
). Fluo-
rescence intensit� was anal�sed pixel b� pixel along the line applied on the merge pictures. When the distance 
between the ma�imal values obtained for green and red fluorescence was less than two pi�els, a co-localization 
event was counted (1). Otherwise, patches were counted as non colocalized (2). 
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Figure 3.21 Quantitative analysis of co-localization events between the wild-type (Wt) or acylation deficient 
(DM)  of 5-HT1A receptor and GM1/CTX. Results presented as mean±S.E. (n=3). A statistically significant 
difference between values is noted (**, p < 0.01).
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Such treatment resulted in the concentration of both labels in less numerous and clearl� de-
fined spots that were scattered over the membrane surface (Figure 3.20A 5-HT1A
Wt,DM
). It is 
also noteworth� that the depletion of cholesterol b� treatment of the intact membrane sheets 
with MßCD resulted in more homogenous distribution of both receptor and GM1 fluores-
cence (Figure 3.20A 5-HT1A
Wt
 MβD treatment). 
 A detailed analysis of the 5-HT1A receptor and GM1-derived fluorescence patterns 
revealed that 30,3±4,1% of the wild-t�pe receptor patches were also enriched with the lipid 
raft marker GM1. Importantly, this value was 3-fold reduced for the acylation-deficient mu-
tant (Figure 3.21). These data demonstrate that a significant fraction of the 5-HT1A receptor 
is associated with the lipid rafts. These findings are also in line with the gradient centrifuga-
tion data suggesting the importance of palmito�lation for localization of the 5-HT1A recep-    
tor in the lipid rafts.
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4	 Discussion
4.1 Role of palmitoylation on 5-HT
4(a)
 receptor functioning
4.1.1	 Phosphorylation	of	the	5-HT
4(a)
	receptor
 Our results demonstrate that the 5-HT
4(a)
 receptor is a substrate for phosphor�lation 
b� endogenous cellular kinase(s) upon exposure to agonist. A prominent role for G-protein 
receptor kinases in the phosphor�lation of the 5-HT
4(a)
 receptor based on following observa-
tions: (i) neither activation nor inhibition of PKA, the kinase activated downstream of  the 
5-HT
4(a)
 receptor, or other second messenger-activated protein kinases, such as protein ki-
nase C or calmodulin kinase, affected 5-HT
4(a)
 receptor phosphor�lation in a noticeable man-
ner; (ii) the 5-HT
4(a)
 receptor is rapidl� (τ
½
=2 min) phosphor�lated upon agonist stimulation, 
and the concentration dependence of receptor phosphor�lation (EC
50
=180 nM 5-HT) strictl� 
followed ligand occupanc�.
 This finding is une�pected, because the receptor’s third intracellular loop as well as 
the carbox�l terminus contains consensus sites for phosphor�lation b� protein kinase C and 
calcium/calmodulin-dependent kinase. A close correlation between dose-dependent recep-
tor phosphor�lation and ligand binding together with the apparent lack of an� effect of sec-
ond messenger-activated protein kinases strongl� suggests the involvement of one or more 
G-protein coupled receptor kinases (GRKs), because they specifically phosphorylate only 
agonist-occupied receptors (Bunemann and Hose� 1999). GRKs from insects and mammals 
are evolutionaril� conserved, which ma� explain wh� these kinases are capable of phos-
phor�lating a wide range of receptor substrates (Cassill et al. 1991). Examination of the 
5-HT
4(a)
 receptor C-terminus reveals the existence of several potential serine or threonine 
phosphor�lation sites. Some of these sites (e.g., Ser382 or Ser385) are highl� conserved 
among human, rat, and murine 5-HT
4(a)
 receptors. These serine residues are flanked by nega-
tivel� charged amino acids, which previousl� were found to promote GRK-mediated phos-
phor�lation (Onorato et al. 1991). Moreover, phosphoamino acid anal�sis revealed that li-
gand induced phosphor�lation of the 5-HT
4{a)
 receptor occurs exclusivel� on serine residues. 
It remains to be determined which of the six C-terminal serine residues, or possibl� other 
serines located on c�toplasmic loops of the receptor, constitute phospho-acceptor sites for 
receptor kinases. 
4.1.2	Interaction	between	palmitoylation	and	phosphorylation
 It is well documented that many GPCRs can be modified by both palmitoylation and 
phosphorylation and that these two post-translational modifications are interrelated. The 
findings of the present study are reminiscent of earlier work on the β2-adrenergic receptor 
in which a C�s341-Gl� palmito�lation mutant found to be h�perphosphor�lated at basal lev-
els could not be enhanced b� further stimulation (Moffett et al. 1993). It was concluded that 
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lack of palmito�lated c�steine exposes a PKA phosphor�lation site juxtaposed to the palmi-
to�lation site. A marked increase in basal phosphor�lation as a result of mutating two puta-
tive c�steine palmito�lation sites was also observed in the A3 adenosine receptor (Palmer 
and Stiles 2000). However, GPCRs in their depalmito�lated states are not alwa�s better tar-
gets for receptor kinases. For e�ample, a palmitoylation-deficient variant of the CCR5 che-
mokine receptor is not efficiently phosphorylated and reveals a profound defect in receptor 
desensitization and internalization (Kraft et al. 2001). Similar defects were observed for the 
vasopressin V1a receptor (Hawtin et al. 2001), whereas elimination of the two palmito�lat-
ed c�steine residues in the related V2 vasopressin receptor did not change basal or agonist-
stimulated phosphor�lation (Sadeghi et al. 1997). Moreover, a mass spectrometric stud� of 
post-translational modifications of the bradykinin B2 receptor revealed that palmitoylation 
at C�s356 and phosphor�lation at T�r352 were mutuall� exclusive (Soskic et al. 1999). 
Taken together, these studies clearl� show that in GPCRs, palmito�lation and phosphor�la-
tion are often interrelated, albeit in different wa�s. 
 Agonist-induced 5-HT
4(a)
 receptor phosphor�lation established in the present stud� 
seems to be functionally significant. Previously it was reported that 5-HT
4
 receptors ex-
pressed in colliculus neurons undergo homologous receptor desensitization (Ansana� et al. 
1992). Neither activation nor inhibition of cAMP-dependent protein kinase affected recep-
tor desensitization, whereas inhibitors of G-protein-coupled receptor kinases, such as hepa-
rin or Zn2+ , caused significant decrease in 5-HT-induced receptor desensitization. Similar 
to the present findings on 5-HT
4(a)
 receptor regulation in a heterologous expression s�stem, 
the 5-HT
4
 receptor desensitization in native tissues also proceeded in a biphasic manner and 
possessed comparable kinetics of the rapid phase of receptor desensitization (Ansana� et al. 
1992). Further support for a role for GRKs in 5-HT
4(a)
 receptor regulation derives from the 
observation that overe�pression of GRK2 significantly enhanced 5-HT
4(a)
 receptor desen-
sitization. A role for PKA in 5-HT
4
 receptor regulation was also suggested recentl� based 
on the observation that receptor-independent activation of PKA could mimic 5-HT induced 
desensitization of the 5-HT
4(d)
 receptor isoforms (Mialet et al. 2003). However, mutation of 
the four PKA consensus sites on this receptor did not impair PKA-induced 5-HT
4(d)
 receptor 
desensitization. In combination with our finding that, on its own, PKA activation did not re-
sult in 5-HT
4(a)
 receptor phosphor�lation, this implies that PKA ma� phosphor�late another 
protein substrate downstream of this receptor. Aden�l�l c�clase, which is inhibited b� PKA 
phosphor�lation (Iwami et al. 1995), is a potential substrate for such a regulation. 
 The 5-HT
4(a)
 receptor is at�pical among GPCRs because of the presence of two sepa-
rate C-terminal palmito�lation sites operating as potential membrane anchorage points at 
positions C�s-328/329 and C�s-386. Together with the observation that the palmito�lation 
state of the receptor is agonist sensitive (Ponimaskin et al. 2001), this dual lipidation sug-
gests that in a native cellular environment, the 5-HT
4(a)
 receptor C terminus exists in sev-
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eral different conformational states that can be modulated b� external stimuli. In the present 
work, we tested the h�pothesis that regulator� c�toplasmic proteins, which bind to or phos-
phor�late the C-terminal domain, ma� interact with these receptor conformers in a differ-
ential manner. Earlier studies in which the same receptor variants were used, revealed that 
mutation of the proximal C�s-328/329 couplet resulted in elevated constitutive activit� of 
this receptor (Ponimaskin et al. 2002a). In contrast, mutations of the distal C�s-386 or of 
all C-terminal palmito�lation sites showed no increase in the basal activit�. We concluded 
from these studies that defective palmito�lation at the proximal membrane anchorage site 
induces a conformation of the 5-HT
4(a)
 C-terminus to facilitate receptor binding and/or ac-
tivation of heterotrimeric G-proteins (Ponimaskin et al. 2002a). Our present finding of el-
evated basal phosphor�lation levels of the proximal C�s328/ 329-Ser mutant ma� be caused 
b� its higher constitutive activit�, as was reported before in other receptor s�stems (Pei et al. 
1994). This interpretation, however, does not explain wh� the C�s386-Ser mutant and the 
completely palmitoylation-deficient receptor are also better substrates for receptor kinases. 
Conformational changes occurring at the C-terminus during basal or agonist-stimulated de-
palmito�lation of the receptor possibl� lead to an exposure of one or several protein kinase 
binding site(s). Such receptor structure seems not to be identical with the conformation that 
is optimal for G-protein activation. Several putative serine phosphor�lation sites are locat-
ed near the palmito�lated C-terminal c�steine residues, which supports the assumption that 
palmito�lation ma� restrain access of these sites to the receptor kinase. Enhanced receptor 
phosphorylation in case of the palmitoylation- deficient mutants could also be caused by the 
presence of additional phospho-acceptor sites that ma� have been introduced b� the conser-
vative replacement of c�steine b� serine residues. However, this seems unlikel�, because the 
triple mutant C�s328/329/386-Ser was phosphor�lated even less than the single or double 
mutants. 
4.1.3	Role	of	palmitoylation	in	β-arrestin2	mediated	desensitization	and	
internalization	of	the	5-HT
4(a)
	receptor
 A receptor with a lack of palmito�lation site seems to be a preferred substrate for 
receptor kinases and is obviousl� most susceptible to ligand-induced desensitization and 
β-arrestin mediated internalization. These findings demonstrate that the palmitoylation sta-
tus of the 5-HT
4(a)
 receptor modifies its ability to interact with other downstream regulatory 
proteins. The receptor mutants were affected in their capacit� to undergo agonist-indepen-
dent receptor activation, phosphor�lation, desensitization and β-arrestin mediated internal-
ization with different rank orders, which suggests that interactions of regulator� proteins 
with the palmito�lated receptor have different structural requirements. Although all recep-
tor mutants were h�perphosphor�lated, onl� the C�s328/329-Ser mutant was rapidl� and 
efficiently internalized in β-arrestin overexpressing cells. Thus, it is unlikel� that GRK-me-
diated h�perphosphor�lation alone is responsible for the enhanced endoc�tosis. Instead, 
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our data suggest that the C�s328/329-Ser receptor mutant, having onl� a single palmi-
toylation site distal to the membrane, represents a specific receptor conformation facilitating 
β-arrestin mediated endoc�tosis. According to the sequential multisite model of β-arrestin 
interaction with ligand-activated receptors, high-affinity binding of arrestin to GPCR in-
volves two separate phosphor�lation-recognition and activation-recognition sites that reside 
within different parts of the molecule (Han et al. 2001). We did not directl� assess β-arrestin 
binding to palmitoylation-deficient receptor mutants, as was reported previously for the 
V2 vasopressin receptor (Charest and Bouvier 2003). In contrast to 5-HT
4(a)
 receptors, non-
palmito�lated V2 vasopressin receptor showed no difference in basal or agonist-induced 
phosphor�lation, but is much more slowl� internalized than wild-t�pe receptors (Charest 
and Bouvier 2003,Sadeghi et al. 1997). Mutation of the palmito�lation site also decreased 
the rate and the extent of β-arrestin recruitment to this receptor. Likewise, receptor palmi-
to�lation was also found to be required for ligand-induced β-arrestin recruitment to the cell 
membrane and endoc�tosis of the th�rotropin-releasing hormone receptor (Groarke et al. 
2001). On the contrar�, mutation of the membrane-proximal palmito�lation site facilitates 
β-arrestin mediated internalization of 5-HT
4(a)
 receptors. 
 In summar�, our stud� shows that 5-HT
4(a)
 receptor palmito�lation is functionall� 
significant, because disruption of C-terminal palmitoylation sites resulted in enhanced re-
ceptor phosphor�lation, desensitization, and β-arrestin-mediated endoc�tosis. Because both 
the phosphor�lation and the palmito�lation status of the 5-HT
4(a)
 receptor are d�namicall� 
regulated b� agonist stimulation, concerted interactions of these two post-translational mod-
ifications seem to play an essential role in modulating the function of 5-HT
4(a)
 receptors. 
4.1.4	Role	of	palmitoylation	in	short	term	interaction	between	5-HT
4(a)	
re-
ceptor	and	β-arrestin2;	BRET2	analysis
 Biochemical methods used in this stud� including measurement of cAMP and ra-
dioligand binding assa� as readout are present classical approaches to anal�ze desensitiza-
tion and internalization of GPCRs. However, these methods require solubilization and con-
centration of membrane proteins which could result in artificial results. In addition, these 
techniques do not allow a d�namical anal�sis of GPCR desensitization in living cells with 
high temporal resolution. On the other hand, initial steps of desensitization in particular in-
teraction between β-arrestin and receptor are known to be quick processes with a time scale 
ranging from milliseconds to seconds (Fotiadis at al. 2006, Lohse et al. 1990). To overcome 
these limitations and to anal�ze receptor desensitization in living cells we applied BRET 
method. Since no external excitation source is needed for BRET assa�s, this approach does 
not suffer from high fluorescent background or photobleaching which take place in fluores-
cence-based FRET method (Miligan 2004, Pfleger and Eidne 2003). Currently this assay 
is often used for anal�sis of receptor oligomeresation (Angers et al. 2001, 2000, Germain-
Desprez et al. 2003, Issafras et al. 2002). However, BRET approach can also be utilized for 
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anal�sis of interaction between GPCRs and β-arrestin (Angers et al. 2000, Kroeger et al. 
2001). Moreover, the BRET method can be extended to give a wealth of information about 
detailed kinetic of interaction over a short period of time (Kroeger et al. 2001). To appl� 
such time-resolved BRET assa� for the anal�sis of 5-HT4 receptor desensitization we create 
fusion constructs between the wild-type and acylation-deficient mutant of 5-HT
4(a)
 receptor 
with Renilla luciferase protein. Functionalit� of receptor-luciferase constructs was assessed 
b� the anal�sis of their subcellular distribution and b� pharmacological studies. In all cases, 
luciferase chimeras demonstrated similar responses as their unlabeled wild-t�pe or ac�la-
tion-deficient counterparts, indicating that Rluc-fused receptors can be used in functional 
studies.
 To stud� short term kinetic of the β-arrestin recruitment to the receptor and anal�zed 
the role of GRK2 in this process, we applied BRET2 assa�. This is a second generation of 
BRET assa�, which utilizes new DeepBlueC™ substrate instead of CoelenterazineC, which 
is a classical substrate for BRET studies. In addition a new version of classical GFP, so 
called GFP2 with changed spectral options is used as an acceptor. These modification result-
ed in improved diference between emmission spectra of luciferase and GFP in comparison 
with a classical BRET assa�. As a consequence of this we have a lower background and bet-
ter signal to noise ratio. 
 To establish the BRET2 method in our laborator� we used the HEK 293 cells  
co-expressing Renilla luciferase–GFP2 chimeric protein as positive control. While cells co-
expressing Renilla luciferase and GFP2 proteins were used as negative controls. These ex-
periments demonstrate that BRET2 assa� is a highl� reproducible method, with a ver� high 
signal to noise ratio. To be able to compare the results from diffirent BRET trials as well 
as use the physiological concentration of the receptor, we defined e�pression level in ev-
er� individual measurement. For that, we used instead of radioligand binding, which is ver� 
time consuming wa� to determine concentration of the receptor, new normalization ap-
proach where we have used linear dependence between the receptor surface expression and 
the donor luminescence intensit�. For this we applied another form of Coelenterazine C 
– Colenterazine H, which allows to measure the absolute luminescence of the donor without 
influencing the energy transfer to a GFP2 (acceptor) mediated b� DeepBlueC (Gales et al. 
2005).
 At first, we analyzed dose dependence of the receptor–β-arrestin2 interaction after 
administration of different concentrations of serotonin. Application of serotonin promote 
β-arrestin interaction with the wild-t�pe form of the 5-HT
4(a)
 receptor as well with its ac�la-
tion-deficient mutants. This was in line with previous observations demonstrating increase 
in receptor–β-arrestin interaction in case of V2 vasopressin and th�rotropin-releasing hor-
mone receptors after stimulation with AVP or TRH respectivel� (Charest and Bouvier 2003, 
Hanyaloglu et al. 2002). Analysis of BRET data for acylation-deficient mutants revealed a 
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high level of basal interaction with β-arrestin. This findings can be e�plained by our previ-
ous observation of a higher basal level of phosphor�lation of these mutants. 
 Activation of the GPCR mediated cascades has been shown to be ver� quick pro-
cess. Activation of G-protein b� the corresponding receptor occurs a few milliseconds af-
ter agonist stimulation, while downstream signaling cascade is activated within hundreds 
of milliseconds. This sugests that receptor phosphor�lation b� receptor kinase followed 
b� β-arrestin binding and desensitization should also start in the time range from millisec-
onds to seconds. To investigate receptor–β-arrestin2 interaction in such short time range 
we applied short kinetic BRET2 anal�sis (Gales et al. 2005). B� this, we anal�zed kinet-
ic of interaction between the 5-HT
4(a)
 receptor and β-arrestin2. Half time of interaction τ
½
 
was calculated for wild-t�pe and all mutants, and was found to be 10.31±1.12, 12.12±2.98, 
19.22±2.08, 21.19±1.77 seconds for the wild-t�pe, C328/29-S, C386-S, C328/29/86-S re-
spectivel�. Slower interaction kinetic (i.e. higher τ
 ½
 values) obtained for acylation-deficient 
mutants ma� be explained b� their higher level of basal phosphor�lation which we obtained 
for all mutants. Such high basal phosphor�lation results in low increase over the basal level 
after agonist stimulation, because of limited numbers of free sites for phosphor�lation at the 
moment of agonist application. This ma� results in relative low rate of recruitment of β-ar-
restin2 to the mutants, resulting in low increase in β-arrestin2 coupling in comparison with 
the wild-t�pe.
 Based on anal�sis of the phosphor�lation of the 5-HT
4(a)
 receptor after activation 
of different protein kinases and staurosporin, we conclude that GRK2 might be main ki-
nase involved in the receptor phosphor�lation. To examine role of this kinase in more de-
tails we utilized BRET2 measurements in the absence or presence of GRK2 wild-t�pe or its 
dominant negative mutant (DNM) (Oppermann et al. 1996). Co-expression of GRK2 Wt 
and DNM did not change kinetic of the receptor–β-arrestin2 interaction (τ
 ½
) for the wild-
type and acylation-deficient mutants. However, BRET values obtained after overe�pression 
of GRK2 for all 5-HT
4(a)
 receptor tested were higher then measured in experiments with-
out GRK2 overexpression. In case of dominant negative form of GRK2, BRET values were 
lower as these obtained for GRK2 Wt overexpression but still higher as values obtained in 
the case without overexpression of GRK2. This phenomenon can be explained b� the recent 
findings describing mechanisms in GRK2 functions. It has been shown that GRK2 has en-
z�matic activit�, and phosphor�lates receptors on their serine/threonine residues quickl� af-
ter receptor activation (Bunemann and Hose� 1999). Moreover it ma� directl� couple to the 
receptor and promotes its desensitization b� serving as an adaptor protein (Oppermann et al. 
1996, Tesmer et al. 2005). Dominant negative mutant lack the enz�matic activit� b� muta-
tion of the l�sine at position 220 to arginine in the catal�tic center of the enz�me (Kong et 
al. 1994, Oppermann et al. 1996). Therefore GRK2 DNM ma� onl� act b� direct binding, 
resulting in a debilitation of the GRK2 activit� (Kong et al. 1994, Opperman et al. 1996, 
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Tesmer et al. 2005).
4.2 Role of palmitoylation in the 5-HT1A receptor functioning
 The convenience of GFP labelling in combination with the recent advances in imag-
ing techniques has not onl� allowed for qualitative, but also quantitative anal�sis of protein 
localization, trafficking and mobility in living cells (Chudakov et al. 2005). More specifi-
cally, fluorescence labelling of GPCRs represents a powerful tool for direct visualization of 
receptor-mediated signalling in real time (Kallal and Benovic 2000,Milligan 2004). In the 
second part of our stud� we used YFP-tagged 5-HT1A receptor wild-t�pe (Wt-YFP) and its 
acylation-deficient mutant (DM-YFP) to analyse their subcellular dynamics and to elucidate 
the role of the receptor palmito�lation. 
Functionalit� of receptor-YFP constructs was assessed b� the anal�sis of their subcellular 
distribution and by pharmacological studies. In addition, the efficiency of downstream sig-
nalling was tested b� receptor-dependent activation of extracellular signal-regulated kinases. 
In all cases, YFP-chimeras demonstrated similar responses as their non-fluorescent wild-
type or acylation-deficient counterparts, indicating that YFP-fused receptors can be used in 
functional studies. In addition, the efficiency of downstream signalling was tested by recep-
tor-dependent activation of extracellular signal-regulated kinases and Ca2+ release. In all 
cases, YFP-chimera demonstrated similar responses as their non-fluorescent wild-type or ac-
ylation-deficient counterparts, indicating that YFP-fused receptors can be used in functional 
studies.
4.2.1	Palmitoylation	and	localization	of	the	5-HT1A	receptor	in	plasma	
membrane	microdomains
 We have previousl� demonstrated that the 5-HT1A receptor is palmito�lated at 
its C-terminal cysteine residues Cys417 and Cys420. Characterization of acylation-defi-
cient 5-HT1A mutants revealed the importance of receptor palmito�lation for the signal-
ing (Papoucheva et al. 2004). However, the molecular mechanisms b� which palmito�lation 
ma� regulate receptor-dependent G-protein activation are still unknown. One possibilit� 
could be the involvement of the 5-HT1A receptor palmitoylation in trafficking and/or local-
ization of the receptor into the specific membrane subdomains, like lipid rafts.
Protein modification by the covalent attachment of saturated fatty acyl chains, including 
m�ristic and palmitic acids represents one of the best characterized lipid raft targeting sig-
nals (Moffett et al. 2000, Zacharias et al. 2002). The long-chain fatt� acids are expected to 
pack well in the l
o
 phase, increasing the avidit� of protein for sphingolipid/cholesterol-en-
riched domains (Melkonian et al. 1999). Accordingl�, a number of ac�lated proteins includ-
ing heterotrimeric G-proteins α−subunits, some Src famil� kinases, GAP-43 are resident in 
the lipid rafts (Arni et al. 1998, Melkonian et al. 1999, Papoucheva et al. 2004). It has been 
also shown that removal of the fatty acid modifications leads to the loss of the protein as-
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sociation with the lipid rafts and caveolae (Shaul et al. 1996, Sheno�-Scaria et al. 1994). It 
is, however, noteworth� that the described results were mainl� obtained on peripheral mem-
brane proteins and cannot be simpl� extended on integral membrane proteins. Importance of 
palmito�lation as a raft targeting signal for the latter remains controversial. For example, it 
has been shown that mutation of all palmito�lated c�steine residues on caveolin-1 does not 
affect its caveolae localization (Dietzen et al. 1995). On the other hand, reconstitution ex-
periments have demonstrated that defined transmembrane peptides become e�cluded from l
o
 
domains regardless of their ac�lation state (van Du�l et al. 2002). For the GPCRs, whose C-
terminal intracellular domains are generall� palmito�lated, the role of ac�lation as a target-
ing signal for the rafts/caveolae localization has not been investigated so far. Several mem-
bers of GPCR superfamil� have been shown to be highl� enriched in lipid rafts and caveo-
lae, whereas others are present onl� in small amounts or excluded from the lipid rafts (Chini 
and Parenti 2004). 
 In the present stud� we found that approximatel� 33% of the wild-t�pe 5-HT1A re-
ceptor resides in the detergent-resistant membrane subdomains (DRMs). Cholesterol deple-
tion results in solubilization of the 5-HT1A receptor, confirming association of the receptor 
with the cholesterol-enriched domains. DRM localization of the 5-HT1A was equall� evi-
dent in different cell t�pes (NIH 3T3 and CHO) suggesting that segregation of the receptor 
into lipid subdomains is intrinsic to the 5-HT1A itself. In contrast to the wild-t�pe receptor, 
population of the acylation-deficient 5-HT1A receptor resided in TritonX-100 insoluble frac-
tions was significantly reduced, suggesting an importance of receptor palmitoylation for the 
DRM trafficking. 
Treatment of cells with non-ionic detergents at low temperature used in this stud� represents 
a classical approach for the DRM isolation. However, this method often produces controver-
sial results and should not be expected to extract lipid rafts from cell membranes precisel� 
(Simons and Vaz 2004). Therefore, we used copatching as an additional assa� to anal�ze 
the membrane distribution of the 5-HT1A receptor. This assa� is based on the observation 
that two membrane components sharing a preference for lipid rafts will coalesce to form 
tightly associated patches after treatment with specific cross-linking reagents, like antibod-
ies or multimeric toxins (Verkade et al. 2000). Anal�sis of copatching data revealed that 
30.3±4.1% of the 5-HT1A receptor was co-localized with the lipid raft ganglioside GM1. 
In contrast, the co-localization of the acylation-deficient mutant with the raft marker was 
drasticall� reduced. Thus, b� using two independent methods we demonstrated that the sig-
nificant fraction of the 5-HT1A receptor resides in lipid rafts in palmitoylation-dependent 
manner. Combined with our previous data on the signaling deficiency of non-palmitoylated 
5-HT1A receptor, this finding suggests that the palmitoylation-dependent raft localization of 
receptor pla�s an essential role in the receptor-mediated signaling processes. 
How can palmito�lation-mediated localization of the 5-HT1A receptor in rafts be involved 
Discussion
in regulation of the receptor activit�? One possible scenario is that the irreversible receptor 
palmito�lation will initiate the transient targeting of the receptor to lipid rafts. Such tran-
sient raft association ma� be further stabilized b� the precoupling of the receptor with the 
Gα
i
 protein (Emerit et al. 1990), which mainl� resides in rafts (Oh and Schnitzer 2001). 
Activation of the receptor will result in dissociation of the receptor bound Gα
i
-protein het-
erotrimeric complex thereb� reducing the fraction of receptor interacting with G-protein 
(Janetopoulos et al. 2001). Such uncoupled receptors have been shown to possess increased 
mobilit� (Janetopoulos et al. 2001) and could therefore leave the lipid microdomains b� the 
lateral diffusion. Outside of lipid rafts, the uncoupled 5-HT1A receptors become “non-func-
tional” in terms of efficient signalling and need to undergo another cycle of raft localiza-
tion to initialize activation of the Gα
i
-protein and downstream effectors upon stimulation. 
Several experimental observations argue for reliabilit� of such model: (i) our data demon-
strate that non-functional, acylation-deficient 5-HT1A mutant is e�cluded from DRMs,  
(ii) removal of cholesterol from hippocampal cells has been found to affect Gα
i
-protein cou-
pling of the 5-HT1A receptor and to affect the specific agonist binding (Pucadyil et al. 2004) 
(iii) it has been shown that differentl� to other GPCRs, prolonged agonist stimulation of 
the 5-HT1A receptor does not result in considerable receptor internalization (Pucad�il et al. 
2004, Riad et al. 2001).
 Taken together, our data demonstrate that stable palmito�lation of the 5-HT1A re-
ceptor represents an important targeting signal responsible for localization of receptor in 
GM1-enriched membrane subdomains. More importantl�, such palmito�lation-dependent 
rafts localization seems to play important role for efficient downstream signaling.
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Summary
 We anal�zed role of 5-HT1A and 5-HT
4(a)
 receptor palmito�lation in the receptor 
functions. In case of 5-HT
4(a)
 receptor we demonstrated that receptor palmito�lation affects 
phosphor�lation. We showed that upon 5-HT stimulation, the 5-HT
4(a)
 receptor undergoes  
rapid (τ
½
=2 min) and dose-dependent (EC
50
=180 nM)  phosphor�lation on serine residues 
by a staurosporine-insensitive receptor kinase. The acylation deficient  (Cys328/29-Ser) mu-
tant, which is constitutivel� active in the absence of ligand, exhibited enhanced receptor 
phosphor�lation under both basal and agonist-stimulated conditions and was more effective-
l� desensitized and internalized via GRK2/β-arrestin pathwa� compared with the wild-t�pe 
5-HT
4(a)
 receptor. G-protein activation, phosphor�lation, desensitization and internalization 
of the other acylaiton deficient receptor mutants were affected differently. Analysis of dy-
namic interactio between receptor and β-arrestin2 b� BRET2 assa� demonstrated that wild-
type and all palmitoylation deficient mutants show accelerated interaction with β-arrestin2 
upon agonist stimulation. Acylation deficient mutants demonstrated a higher basal level of 
interaction with β-arrestin2 than the wild-t�pe, but a slower interaction kinetic (τ
½
=12 sec. 
for C�s328/29-S vs. 10 seconds for the wild-t�pe) after stimulation with agonist.  Co-ex-
pression of wild-t�pe form of the GRK2 promotes receptor–β-arrestin2 interaction, while 
dominant negative mutant slightl� reduce this affect, suggesting that the positive effect of 
GRK on receptor–β-arrestin2 interaction is mediated both b� enz�matic activit� as well as 
by direct interaction of GRK2 with the receptor. These findings suggest that palmitoylation 
pla�s an important role in modulating 5-HT
4(a)
 receptor functions and that G-protein activa-
tion, phosphor�lation, desensitization, and internalization of the receptor are regulated b� 
this dynamic modification. 
 In the second part of the stud� we addressed the question on the molecular mecha-
nisms b� which receptor palmito�lation ma� regulate communication between receptors and 
Gα
i
-proteins. In contrast to 5-HT
4(a)
 receptor, which undergoes d�namic pamito�lation, pal-
mitoylation of  5-HT1A  is an irreversible  modification. Our data demonstrate that activa-
tion of the 5-HT1A receptor caused an activation of Gα
i3
 protein. In contrast, acylation-defi-  
cient 5-HT1A mutant failed to reproduce Gα
i3
 activation upon agonist stimulation. B� using 
gradient centrifugation and co-patching assays, we also demonstrated that a significant frac-
tion of the 5-HT1A receptor resides in lipid rafts, while the �ield of the palmito�lation-de-    
ficient receptor in these membrane microdomains is considerably reduced. These data sug-   
gest that receptor palmito�lation serves as a targeting signal responsible for the retention of 
the 5-HT1A receptor in lipid rafts, and the raft localization of the 5-HT1A receptor appears 
to be involved in receptor-mediated signaling.
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